Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Javier Cortes
Based on 116 articles published since 2008
||||
Expertise Level
The expertise of Javier Cortes ranks in the
  • Top 0.0047%
  • ... of 255,217 published authors worldwide on Breast Neoplasms
  • ... from 2008 through 2018
  • ... based on contributions to 116 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Cortés, Javier   ·   Cortes, Javier
Work Locations
Details
Most likely:    Universitat Autonoma de Barcelona      
2018
  • Department of Medical Oncology, Acıbadem University School of Medicine, Istanbul, Turkey. Electronic address: · Cancer Research UK Clinical Centre, St James' University Hospital, Leeds, UK. Electronic address: · Center Eugène Marquis, Rennes, France. Electronic address: · Medical Oncology Department, Ramon y Cajal University Hospital, Madrid, Spain; Medical Oncology Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Electronic address: · Medical Oncology Clinic, Institut Jules Bordet Universite Libre de Bruxelles, Brussels, Belgium. Electronic address: · Pubmed 29329006
  • National Center for Tumor Diseases, University Hospital, Heidelberg, Germany. Electronic address: · British Columbia Cancer Agency - Vancouver Centre, University of British Columbia, Vancouver, Canada. · Royal Bournemouth Hospital, Bournemouth University, Bournemouth, UK. · Regional Cancer and Blood Services, Auckland City Hospital, Auckland, New Zealand. · Cancer Institute "Ion Chiricuta", Cluj-Napoca, Romania. · Clinical Science, Global Product Development, Roche Products Limited, Welwyn Garden City, UK. · Product Development - Oncology, Genentech, Inc., South San Francisco, CA, USA. · PDBB - Biostatistics, Roche Products Limited, Welwyn Garden City, UK. · Ramón y Cajal University Hospital, Madrid and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Pubmed 29223479
2017
  • Ramón y Cajal University Hospital, Carretera de Colmenar Viejo, 9.100, 28034 Madrid, Spain; Vall d'Hebron Institute of Oncology, Psg. Vall d'Hebron 119-129, Barcelona, Spain. Electronic address: · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, 101 Daehak-ro, Jongro-gu, Seoul, Republic of Korea. · Ramón y Cajal University Hospital, Carretera de Colmenar Viejo, 9.100, 28034 Madrid, Spain; Baselga Institute of Oncology, Ruber & San Camilo Hospitals, Madrid, Spain. · Baselga Institute of Oncology, Hospital Quiron, Plaza Alfonso Comín, 5, Barcelona, Spain. · Barts Cancer Institute, Queen Mary University of London, Old Anatomy Building, Ashfield Street, London, UK. · MD Anderson Cancer Center, University of Texas, 1515 Holcombe Blvd, Houston 77030, TX, USA. · Pubmed 29100169
  • Hospital Sirio Libanes, Adma Jafet St 91, 1308050 São Paulo, Brazil. · Ramon y Cajal University Hospital, Ctra. Colmenar Viejo km. 9, 100, 28034 Madrid, Spain; Vall d'Hebron Institute of Oncology, Centro Cellex, Calle Natzaret 115-117, 08035 Barcelona, Spain. Electronic address: · European Institute of Oncology, Via Ripamonti 435, 20146 Milano, Italy. Electronic address: · Peter MacCallum Cancer Centre, University of Melbourne, Grattan Street 305, 3000 Melbourne, Australia. Electronic address: · Institute of Pathology, Charité Universitätsmedizin Berlin and German Cancer Consortium (DKTK), Campus Mitte, Charitéplatz 1, D-10117 Berlin, Germany. Electronic address: · Baselga Oncological Institute, Quiron Hospital, Plaça d'Alfonso Comín 5, 08023 Barcelona, Spain. Electronic address: · Ramon y Cajal University Hospital, Ctra. Colmenar Viejo km. 9, 100, 28034 Madrid, Spain; Baselga Institute of Oncology, Madrid, Spain. Electronic address: · Pubmed 29061314
  • UCSF Helen, Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, San Francisco, CA, 94115, USA. · Centre Léon Bérard, Lyon, France. · National Cancer Center, Goyang, Republic of Korea. · H. de Lleida Arnau de Vilanova, Lerida, Spain. · Institut de Cancérologie de l'Ouest, St Herblain-Nantes, France. · University Hospital of Parma, Parma, Italy. · Instituto Português de Oncologia Francisco Gentil, Porto, Portugal. · Korea University Medical Center, Seoul, Republic of Korea. · Ramón y Cajal University Hospital, Madrid and Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. · Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. · Merck& Co., Inc., Kenilworth, NJ, USA. · Checkmate Pharmaceuticals, Cambridge, MA, USA. · Alexion Pharmaceuticals, New Haven, CT, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 28681171
  • Department of Medicine and Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: · Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan. · Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid, Spain; Vall d'Hebron Institute of Oncology, Barcelona, Spain; Instituto Oncológico Baselga, Hospital Quirónsalud, Barcelona, Spain. · Department of Breast Oncology, Istituto Nazionale Tumouri Fondazione G Pascale, Naples, Italy. · Department of Breast Cancer, Beijing 307 Hospital of PLA, Beijing, China. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Department of Gynecology, University Hospital Schleswig-Holstein, Kiel, Germany. · Division of Medical Oncology, Ottawa Hospital Research Institute, Ottawa, ON, Canada. · Department of Radiation Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan. · Medicine Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, BC Cancer Agency, Vancouver, BC, Canada. · Department of Breast Cancer and Reconstruction Surgery, Maria Skłodowska Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland. · Department of Oncology, Ospedale di Macerata, Macerata, Italy. · Department of Surgery, Taipei Veterans General Hospital, National Yang Ming University, Taipei, Taiwan. · Division of Haematology-Oncology, Department of Medicine, University of California, Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Breast Oncology, Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan. · Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan. · Department of Medical Oncology, Université Catholique de Louvain, CHU UCL, Namur, Belgium. · Novartis Pharma SAS, Paris, France. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Syros Pharmaceuticals, Watertown, MA, USA. · Novartis Pharma AG, Basel, Switzerland. · Institut de Cancérologie de l'Ouest-René Gauducheau Centre de Recherche en Cancérologie, Nantes, France. · Pubmed 28576675
  • Leeds Institute of Cancer and Pathology and St James's Institute of Oncology, Leeds, UK. Electronic address: · Ramon y Cajal University Hospital, Madrid, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Baylor-Sammons Cancer Center, Texas Oncology, U.S. Oncology, Dallas, TX, USA. · Medical Oncology Clinic, Jules Bordet Institute, Brussels, Belgium. · Mayo Clinic, Jacksonville, FL, USA. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · The West Clinic, Memphis, TN, USA. · Institut Curie, Paris, France. · Sarah Cannon Research Institute, Nashville, TN, USA. · University of Minnesota, Department of Medicine, Masonic Cancer Center, Minneapolis, MN, USA. · Centre Oscar Lambret, Lille, France. · Ramon y Cajal University Hospital, Madrid, Spain. · Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. · Nektar Therapeutics, San Francisco, CA, USA. · Consultant, Sebastopol, CA, USA. · University of California, San Francisco, CA, USA. · Pubmed 28360015
  • Memorial Sloan Kettering Cancer Center, New York, NY, USA. · H. de Lleida Arnau de Vilanova, Lérida, Spain. · Institut Jules Bordet, Brussels, Belgium. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. · Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. · Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA. · Institute of Clinical Research, Odense University Hospital, University of Southern Denmark, Odense, Denmark. · Ramon y Cajal University Hospital, Madrid and Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Massachusetts General Hospital, Boston, MA, USA. · Mayo Clinic, Rochester, MN, USA. · University of Minnesota Masonic Clinical Cancer Center, Minneapolis, MN, USA. · Hospital 12 de Octubre, Madrid, Spain. · Clinique Sainte Elisabeth, Namur, Belgium. · Merck & Co., Inc., Kenilworth, NJ, USA. · Checkmate Pharmaceuticals, Cambridge, MA, USA. · UCSF Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero St., San Francisco, CA, USA. · Pubmed 28324268
  • Hospital Arnau de Vilanova, Valencia, Spain. · Hospital Universitario Ramón y Cajal, Madrid, Spain; Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Hospital Clinic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Vall d'Hebron Institute of Oncology, Barcelona, Spain; Hospital Clinic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Hospital Clínico de Valencia, Valencia, Spain. · Hospital Universitario Ramón y Cajal, Madrid, Spain. · Hospital Clinic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Hospital Universitari Vall d' Hebron, Barcelona, Spain. · Instituto Catalán de Oncología, Hospitalet, Barcelona, Spain. · Complejo Universitario de Santiago de Compostela, Santiago de Compostela, Spain. · Hospital Clinic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Molecular Oncology Laboratory, Barcelona, Spain. · Hospital Universitari Arnau Vilanova, Lleida, Spain. · Hospital Universitari Vall d' Hebron, Barcelona, Spain. · SOLTI Breast Cancer Research Group, Barcelona, Spain. · Vall d'Hebron Institute of Oncology, Barcelona, Spain; Hospital Clinic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. Electronic address: · Pubmed 28238593
  • Breast Cancer Clinical Research Unit, CNIO - Spanish National Cancer Research Center, Madrid, Spain. · Medical Oncology Department, Hospital Clinico Universitario, Valencia, Spain. · Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain. · Medical Oncology Department, Hospital de Montepríncipe, Madrid, Spain. · Medical Oncology Department, Hospital Vall d'Hebron, Barcelona, Spain. · Medical Oncology Department, Hospital Ramón y Cajal, Madrid, Spain. · Medical Oncology Department, Hospital Clinico San Carlos, Madrid, Spain. · Medical Oncology Department, Institut Catala d'Oncologia-IDIBELL, L'Hospitalet de Llobregat, Spain. · Medical Oncology Department, MD Anderson Cancer Center, Madrid, Spain. · Medical Oncology Department, Hospital General de Albacete, Albacete, Spain. · Medical Oncology Department, Hospital Lozano Blesa, Zaragoza, Spain. · Medical Oncology Department, Institut Catala d'Oncologia-Josep Trueta, Girona, Spain. · Medical Oncology Department, Hospital Arnau de Vilanova, Valencia, Spain. · Medical Oncology Department, Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain. · Medical Oncology Department, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain. · Breast Cancer Clinical Research Unit, CNIO - Spanish National Cancer Research Center, Madrid, Spain. · GEICAM, Madrid, Spain. · Pathology Department, Hospital Ramon y Cajal, Madrid, Spain. · Molecular Imaging Unit, CNIO - Spanish National Cancer Research Center, Madrid, Spain. · Medical Oncology Department, Hospital Universitario La Princesa, Madrid, Spain. · Pubmed 27587436
  • Breast Cancer Clinical Research Unit, CNIO-Spanish National Cancer Research Center, Madrid, Spain. · Telomeres and Telomerase Group, Molecular Oncology Programme, CNIO-Spanish National Cancer Research Center, Madrid, Spain. · Medical Oncology Department, Hospital Clinico Universitario, Valencia, Spain. · Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain. · Medical Oncology Department, Hospital de Montepríncipe, Madrid, Spain. · Medical Oncology Department, Hospital Vall d´Hebron, Barcelona, Spain. · Medical Oncology Department, Hospital Ramón y Cajal, Madrid, Spain. · Medical Oncology Department, Hospital Clinico San Carlos, Madrid, Spain. · Medical Oncology Department, Institut Catala d'Oncologia-IDIBELL, L'Hospitalet de Llobregat, Spain. · Medical Oncology Department, MD Anderson Cancer Center, Madrid, Spain. · Medical Oncology Department, Hospital General de Albacete, Albacete, Spain. · Medical Oncology Department, Hospital Lozano Blesa, Zaragoza, Spain. · Medical Oncology Department, Institut Catala d'Oncologia-Hospital Dr. Josep Trueta, Girona, Spain. · Medical Oncology Department, Hospital Arnau de Vilanova, Valencia, Spain. · Medical Oncology Department, Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain. · Medical Oncology Department, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain. · GEICAM, Madrid, Spain. · Medical Oncology Department, Hospital Universitario La Princesa, Madrid, Spain. · Pubmed 28423524
  • Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Morphological Sciences Department, Universidad Autónoma de Barcelona, Spain. Electronic address: · Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Morphological Sciences Department, Universidad Autónoma de Barcelona, Spain. · Pathology Department, Virgen del Rocío University Hospital, Sevilla, Spain. · Pathology Department, Hospital Lluis Alcanys, Xàtiva, Spain. · Pathology Department, Hospital de la Ribera, Alcira, Spain. · Pathology Department, Hospital de Navarra, Pamplona, Spain. · Pathology Department, Salamanca University Hospital, Spain. · Pathology Department, Complejo Hospitalario de Jaén, Spain. · Pathology Department, Hospital Arnau de Vilanova, Lérida, Spain. · Pathology Department, Fundación Jiménez Díaz, Madrid, Spain. · Breast Cancer Unit, Vall d'Hebron University Hospital, Barcelona, Spain. · Medical Oncology Department, Baselga Institute of Oncology, Quiron Hospital, Barcelona, Spain. · Medical Oncology Department, Ramón y Cajal University Hospital, Madrid, Spain; Vall d'Hebron Oncology Institute, Barcelona, Spain. · Pubmed 28254641
2016
  • Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA. · Medical Oncology Department, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Paseo Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Faculty of Medicine, Universitat Autònoma de Barcelona (UAB), Campus de la UAB, Plaza Cívica, 08193 Bellaterra, Barcelona, Spain. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA. · Ramon y Cajal University Hospital, Ctra. de Colmenar Viejo, 28034 Madrid, Spain. · Medica Scientia Innovation Research (MedSIR), C/ Rambla Catalunya 2, 2D, 08007 Barcelona, Spain. · Pubmed 27000962
  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain and Ramony Cajal University Hospital, Madrid, Spain. · University of California Los Angeles, Los Angeles, CA, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · MD Anderson Cancer Center, Houston, TX, USA. · Sunnybrook Odette Cancer Centre, Toronto, Canada. · Merrimack Pharmaceuticals, Inc., 1 Kendall Square, Suite B7201, Cambridge, MA, 02139-1670, USA. · Merrimack Pharmaceuticals, Inc., 1 Kendall Square, Suite B7201, Cambridge, MA, 02139-1670, USA. · Sarah Cannon Research Institute, and Tennessee Oncology, PLLC, Nashville, TN, USA. · Pubmed 27259714
  • Biochemistry Department, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas "Alberto Sols" (CSIC-UAM), IdiPAZ, Madrid, Spain. · Preclinical Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. · Pathology Department, MD Anderson Cancer Center, Madrid, Spain. · Breast Cancer and Systems Biology Unit, ProCURE, Catalan Institute of Oncology, IDIBELL, L'Hospitalet del Llobregat, Barcelona, Spain. · Translational Research Laboratory, MD Anderson Internacional Foundation, Madrid, Spain. · Cytogenetics Department, MD Anderson Cancer Center, Madrid, Spain. · Pathology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain. · Oncology Department, MD Anderson Cancer Center, Madrid, Spain. · Clinical Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autonoma de Barcelona, Barcelona, Spain. · Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Molecular Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. · Pathology Department, Hospital Vall d'Hebron University, Barcelona, Spain. · Pathology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Pubmed 27462779
  • Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Universitat Autònoma de Barcelona, Plaça Cívica, 08193 Bellaterra (Cerdanyola del Vallès), Spain. · OncoPlex Diagnostics (Division of NantOmics, LLC), 9600 Medical Center Drive, Suite 300, Rockville, MD 20850, USA. · Department of Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Department of Pathology, Vall d'Hebron University Hospital, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Preclinical Research Program, Vall d'Hebron Institute of Oncology, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain. · Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Pubmed 26422389
2015
  • Vall d'Hebron Institute of Oncology, Barcelona, Spain and Ramon y Cajal University Hospital, Madrid, Spain. Electronic address: · Institut Curie, Paris, France. · National Cancer Center, Goyang-si, Republic of Korea. · Centre Antoine Lacassagne, Nice, France. · Centre Léon Bérard, Lyon, France. · University of California, Los Angeles, CA, USA. · Centre Oscar Lambret, Lille, France; University Hospital, Lille, France. · Hôpital Saint-Louis, Paris, France. · Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · National Center for Tumor Diseases, University Hospital, Heidelberg, Germany. · Severance Hospital, Sinchon-dong, Seodaemun-gu, Seoul, South Korea. · Centre Jean Perrin, Clermont-Ferrand, France. · Tampere University Hospital and University of Tampere, Tampere, Finland. · Sansum Clinic, Santa Barbara, CA, USA. · Università di Modena e Reggio Emilia, Modena, Italy. · Hospital Universitario 12 de Octubre, Madrid, Spain. · Comprehensive Cancer Center, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland. · Boehringer Ingelheim, Paris, France. · Boehringer Ingelheim, Reims, France. · Pubmed 26596672
  • Mayo Clinic, Jacksonville, FL, USA. Electronic address: · Medical Oncology Clinic, Jules Bordet Institute, Brussels, Belgium. · Baylor-Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. · University of California, San Francisco, CA, USA. · University of Leeds and St James's University Hospital, Leeds, UK. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · The West Clinic, Memphis, TN, USA. · Institut Curie, Paris, France. · Sarah Cannon Research Institute, Nashville, TN, USA. · University of Minnesota Department of Medicine and Masonic Cancer Center, Minneapolis, MN, USA. · Centre Oscar Lambret, Lille, France. · Mayo Clinic, Jacksonville, FL, USA. · Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. · Nektar Therapeutics, San Francisco, CA, USA. · Sebastopol, CA, USA. · Vall d'Hebron Institute of Oncology, Barcelona, Spain; Ramon y Cajal University Hospital, Madrid, Spain. · Pubmed 26482278
  • Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, P. Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA. · Universitat Autònoma de Barcelona, 08193 Barcelona, Spain. · Vall d'Hebron Institute of Research, Vall d'Hebron University Hospital, Ps Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. · Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Quirón Dexeus University Hospital, 08028 Barcelona, Spain. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Pubmed 26554728
  • Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain. · Oncology Experimental Therapeutics Unit, IRCCS Humanitas Clinical and Research Institute, Rozzano, Milan, Italy. · Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Division of Pathology, IRCCS Humanitas Clinical and Research Institute, Rozzano, Milan, Italy, University of Milan, Milan, Italy. · Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands. · Cancer Pharmacology Laboratory, AIRC Start-Up Unit, University of Pisa, Pisa, Italy. · Pathology Department, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain. · Division of Oncology and Hematology, IRCCS Humanitas Clinical and Research Institute, Rozzano, Milan, Italy. · Deparment of Clinical and Biomedical Sciences "Luigi Sacco", University of Milan, Milan, Italy. · Ramon y Cajal University Hospital, Madrid, Spain. · Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. · Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 26452030
  • Preclinical Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, 08035, Barcelona, Spain; Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Campus de la UAB, 08193, Bellaterra, Spain. · Pathology Department, Vall d'Hebron University Hospital, 08035, Barcelona, Spain. · Preclinical Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, 08035, Barcelona, Spain. · Molecular Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, 08035, Barcelona, Spain. · Pathology Department, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, 46010, Valencia, Spain. · Oncology Department, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, 46010, Valencia, Spain. · Clinical Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, 08035, Barcelona, Spain. · Translational Research Department, Institut Curie, 75005, Paris, France. · Novartis Oncology Translational Research, Cambridge, MA, 02139, United States of America. · Novartis Pharma AG, Postfach, CH-4002, Basel, Switzerland. · Preclinical Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, 08035, Barcelona, Spain; Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Campus de la UAB, 08193, Bellaterra, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010, Barcelona, Spain. · Pubmed 26075403
  • University of Leeds and St James' Institute of Oncology, Leeds, United Kingdom · St James' Institute of Oncology, Leeds, United Kingdom. · Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Pubmed 25732168
2014
  • Breast Cancer Unit, Vall d׳Hebron Institute of Oncology, Vall d׳Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain. · Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY. Electronic address: · Pubmed 25440604
  • German Breast Group, Neu-Isenburg, and University Women's Hospital, Frankfurt, Germany. Electronic address: · University Hospital of Udine, Udine, Italy. · Vall d'Hebron Institute of Oncology and Vall d'Hebron University Hospital, Barcelona, Spain. · Center of Oncology, University Hospital Split, Split, Croatia. · Outpatient Cancer Center, Freiburg, Germany. · Department of Medicine I and Comprehensive Cancer Center, Medical University Vienna, Vienna, Austria; Central European Cooperative Oncology Group, Vienna, Austria. · Centre Hospitalier-Universitaire de Besançon, Besançon, France. · Institut du Cancer Montpellier, Val d'Aurelle, France. · National Institute of Oncology, Budapest, Hungary. · Hospital Universitario 12 Octubre, Madrid, Spain. · Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy. · Centre Henri Becquerel, Rouen, France. · F Hoffmann-La Roche Ltd, Basel, Switzerland. · Assistance-Publique Hôpitaux de Paris-Tenon, Institut Universitaire de Cancerologie Université Pierre et Marie Curie, Sorbonne Université, Paris, France. · Pubmed 25273342
  • Medica Scientia Innovation Research (MedSIR ARO), Barcelona, Spain; Hospital Arnau de Vilanova de Valencia, Valencia, Spain. Electronic address: · Institut Regional du Cancer en Franche-Comté, Centre Hospitalier Universitaire de Besançon, Besançon, France. · Sandro Pitigliani Medical Oncology Department, Nuovo Ospedale di Prato, Istituto Toscano Tumori, Prato, Italy. · University Hospital 12 de Octubre, Madrid, Spain. · Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada. · Institut Curie, Université Paris Descartes, Paris, France. · Royal Marsden Hospital and The Institute of Cancer Research, London, UK. · Department of Gynaecology, Martin-Luther-Universität Halle-Wittenberg, Halle an der Saale, Germany. · F Hoffmann-La Roche Ltd, Basel, Switzerland. · Medica Scientia Innovation Research (MedSIR ARO), Barcelona, Spain; Scienco Klinico, Barcelona, Spain. · Medica Scientia Innovation Research (MedSIR ARO), Barcelona, Spain; Vall d'Hebron University Hospital, Barcelona, Spain. · Pubmed 25047747
  • Breast Surgical Unit, Breast Cancer Center, Vall d'Hebron Instituto de Oncología. Hospital Universitario Vall d'Hebron. Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address: · Department of Pathology, Vall d'Hebron Instituto de Oncología. Hospital Universitario Vall d'Hebron. Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Radiation Oncology, Vall d'Hebron Instituto de Oncología. Hospital Universitario Vall d'Hebron. Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Medical Oncology, Breast Cancer Center, Vall d'Hebron Instituto de Oncología. Hospital Universitario Vall d'Hebron. Universitat Autònoma de Barcelona, Barcelona, Spain. · Breast Surgical Unit, Breast Cancer Center, Vall d'Hebron Instituto de Oncología. Hospital Universitario Vall d'Hebron. Universitat Autònoma de Barcelona, Barcelona, Spain. · Pubmed 24703804
  • *Authors contributed equally to this work. · *Authors contributed equally to this work.Affiliations of authors: Preclinical Research (JLPP, BM, ME, RV, MZF, KP, VS, AP, JA) and Clinical Research Programs (PN, JC, ITR), Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain (VP); Human Oncology and Pathogenesis Program (HOPP) and Memorial Sloan Kettering Cancer Center, New York, NY (MS, JB); Instituto de Biología Molecular y Celular del Cáncer, Campus Miguel de Unamuno, Salamanca, Spain (AP); Lineberger Comprehensive Cancer Center, Chapel Hill, NC (CMP); Department of Biochemistry and Molecular Biology, Universitat Autonoma de Barcelona, Campus de la UAB, Bellaterra, Spain (JA); Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (JA). · Pubmed 25253614
  • Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Medical Oncology, Institut Curie, Paris, France. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain. · Universitat Autònoma de Barcelona, Barcelona, Spain; Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain. · Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; Universitat Autònoma de Barcelona, Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. Electronic address: · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. Electronic address: · Pubmed 24220311
2012
  • Breast Cancer Program, Department of Oncology, Vall d'Hebron University Hospital, Vall d'Hebron 119-129, Barcelona, Spain. · Pubmed 22113255
  • Department of Oncology, Vall d'Hebron University Hospital, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Pubmed 21872996
  • Department of Oncology, Vall d´Hebron University Hospital, Barcelona, Spain. · Pubmed 21550727
  • Department of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain. · Pubmed 22196033
  • Department of Oncology, Vall d'Hebron University Hospital, P° Vall d'Hebron 129-139, 08035 Barcelona, Spain; · Pubmed 22927522
2011
  • Vall d'Hebron University Hospital, Oncology Department, Breast Cancer Unit, Paseo Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Pubmed 21151204
  • Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Pubmed 21376385
  • Department of Medical Oncology, Breast Cancer Unit, Vall d'Hebron University Hospital, 08035 Barcelona, Spain. · Pubmed 21375468
2010
2014
  • José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY; Javier Cortés, Vall d'Hebron University Hospital, Barcelona, Spain; Seock-Ah Im, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Emma Clark and Graham Ross, Roche Products, Welwyn Garden City, United Kingdom; Astrid Kiermaier, F. Hoffmann-La Roche, Basel, Switzerland; and Sandra M. Swain, Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC. · José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY; Javier Cortés, Vall d'Hebron University Hospital, Barcelona, Spain; Seock-Ah Im, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Emma Clark and Graham Ross, Roche Products, Welwyn Garden City, United Kingdom; Astrid Kiermaier, F. Hoffmann-La Roche, Basel, Switzerland; and Sandra M. Swain, Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC. · Pubmed 25332247
  • Cristina Saura and Javier Cortés, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona; Jose A. Garcia-Saenz, Hospital Clinico San Carlos; Miguel Martin, Hospital Gregorio Maranon, Universidad Complutense, Madrid, Spain; Binghe Xu, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China; Wael Harb, Horizon Medical Group, Lafayette, IN; Rebecca Moroose, University of Florida Health Cancer Center, Orlando, FL; Timothy Pluard, Washington University School of Medicine, St Louis, MO; Corinne Kiger, Pfizer Global Research and Development, Paris; Caroline Germa, Novartis Pharma, Rueil-Malmaison, France; Kongming Wang, Pfizer, Pearl River; José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY; and Sung-Bae Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · Cristina Saura and Javier Cortés, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona; Jose A. Garcia-Saenz, Hospital Clinico San Carlos; Miguel Martin, Hospital Gregorio Maranon, Universidad Complutense, Madrid, Spain; Binghe Xu, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China; Wael Harb, Horizon Medical Group, Lafayette, IN; Rebecca Moroose, University of Florida Health Cancer Center, Orlando, FL; Timothy Pluard, Washington University School of Medicine, St Louis, MO; Corinne Kiger, Pfizer Global Research and Development, Paris; Caroline Germa, Novartis Pharma, Rueil-Malmaison, France; Kongming Wang, Pfizer, Pearl River; José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY; and Sung-Bae Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · Pubmed 25287822
  • University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain; Weill Cornell Medical College, New York, New York, USA; Jules Bordet Institute, Brussels, Belgium; University of Leeds and St James's Institute of Oncology, Leeds, UK; Formerly of Eisai Ltd, Hatfield, UK; Eisai Inc., Woodcliff Lake, New Jersey, USA; NJS Associates Company, Somerset, New Jersey USA; Baylor-Charles A. Sammons Cancer Center, Texas Oncology, and US Oncology, Dallas, Texas, USA. · Pubmed 24682463
2013
  • Medical Oncology Department, Vall d'Hebron Institute of Oncology, Vall D'Hebron University Hospital, Barcelona, Spain. · Pubmed 23881722
  • Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Paseo Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Pubmed 23712187
  • aVall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain bMedStar Washington Hospital Center, Washington Cancer Institute, Washington, District of Columbia cMid Ohio Oncology/Hematology Inc., The Mark H. Zangmeister Center, Columbus, Ohio dGenentech, South San Francisco, California eMemorial Sloan-Kettering Cancer Center, New York, New York, USA fRiga East University Hospital Oncology Center, Riga, Latvia gDaugavpils Reǵionālā Slimnīca, Daugavpils, Latvia hGesundheitszentrum Fricktal, Spital Rheinfelden & Laufenburg, Rheinfelden, Switzerland iNational Hospital Organization Osaka National Hospital, Osaka-City, Osaka, Japan jRoche Products Limited, Welwyn Garden City, UK kPharsight, Montreal, Quebec, Canada. · Pubmed 23969513
  • Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain. · Pubmed 23932547
  • From the Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Medica Scientia Innovation Research (MedSIR), Passeig Vall d'Hebron, Barcelona, Spain. · Pubmed 23714447
  • Breast Cancer Center, Vall d'Hebron University Hospital, Passeig de la Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Pubmed 23137566
  • Vall d'Hebron Breast Cancer Center, Service of Gynecology, Hospital Universitari Vall d'Hebron, Barcelona, Spain. · Pubmed 23116970
  • Affiliations of authors: Department of Oncology, IRCCS Fondazione Istituto Nazionale dei Tumori, Milano, Italy (SDC); Department of Oncology (LdM, JC), and Beast Cancer Surgery (IR), Vall d'Hebron University Hospital, Barcelona, Spain. · Pubmed 24218522
2012
  • Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain. · Pubmed 22523199
  • Medical Oncology Department, Vall D'Hebron University Hospital, Paseo Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Pubmed 22560618
  • Breast Cancer Unit, Service of Gynecology, Hospital Vall d'Hebron, Barcelona, Spain. · Pubmed 22018510
2010
  • Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Paseo Vall d'Hebron 119-129, Barcelona, Spain E-08035. · Pubmed 20124182
Probable:    Hospital Ramon y Cajal      
2018
  • Department of Medical Oncology, Acıbadem University School of Medicine, Istanbul, Turkey. Electronic address: · Cancer Research UK Clinical Centre, St James' University Hospital, Leeds, UK. Electronic address: · Center Eugène Marquis, Rennes, France. Electronic address: · Medical Oncology Department, Ramon y Cajal University Hospital, Madrid, Spain; Medical Oncology Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Electronic address: · Medical Oncology Clinic, Institut Jules Bordet Universite Libre de Bruxelles, Brussels, Belgium. Electronic address: · Pubmed 29329006
  • National Center for Tumor Diseases, University Hospital, Heidelberg, Germany. Electronic address: · British Columbia Cancer Agency - Vancouver Centre, University of British Columbia, Vancouver, Canada. · Royal Bournemouth Hospital, Bournemouth University, Bournemouth, UK. · Regional Cancer and Blood Services, Auckland City Hospital, Auckland, New Zealand. · Cancer Institute "Ion Chiricuta", Cluj-Napoca, Romania. · Clinical Science, Global Product Development, Roche Products Limited, Welwyn Garden City, UK. · Product Development - Oncology, Genentech, Inc., South San Francisco, CA, USA. · PDBB - Biostatistics, Roche Products Limited, Welwyn Garden City, UK. · Ramón y Cajal University Hospital, Madrid and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Pubmed 29223479
2017
  • Ramón y Cajal University Hospital, Carretera de Colmenar Viejo, 9.100, 28034 Madrid, Spain; Vall d'Hebron Institute of Oncology, Psg. Vall d'Hebron 119-129, Barcelona, Spain. Electronic address: · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, 101 Daehak-ro, Jongro-gu, Seoul, Republic of Korea. · Ramón y Cajal University Hospital, Carretera de Colmenar Viejo, 9.100, 28034 Madrid, Spain; Baselga Institute of Oncology, Ruber & San Camilo Hospitals, Madrid, Spain. · Baselga Institute of Oncology, Hospital Quiron, Plaza Alfonso Comín, 5, Barcelona, Spain. · Barts Cancer Institute, Queen Mary University of London, Old Anatomy Building, Ashfield Street, London, UK. · MD Anderson Cancer Center, University of Texas, 1515 Holcombe Blvd, Houston 77030, TX, USA. · Pubmed 29100169
  • Hospital Sirio Libanes, Adma Jafet St 91, 1308050 São Paulo, Brazil. · Ramon y Cajal University Hospital, Ctra. Colmenar Viejo km. 9, 100, 28034 Madrid, Spain; Vall d'Hebron Institute of Oncology, Centro Cellex, Calle Natzaret 115-117, 08035 Barcelona, Spain. Electronic address: · European Institute of Oncology, Via Ripamonti 435, 20146 Milano, Italy. Electronic address: · Peter MacCallum Cancer Centre, University of Melbourne, Grattan Street 305, 3000 Melbourne, Australia. Electronic address: · Institute of Pathology, Charité Universitätsmedizin Berlin and German Cancer Consortium (DKTK), Campus Mitte, Charitéplatz 1, D-10117 Berlin, Germany. Electronic address: · Baselga Oncological Institute, Quiron Hospital, Plaça d'Alfonso Comín 5, 08023 Barcelona, Spain. Electronic address: · Ramon y Cajal University Hospital, Ctra. Colmenar Viejo km. 9, 100, 28034 Madrid, Spain; Baselga Institute of Oncology, Madrid, Spain. Electronic address: · Pubmed 29061314
  • Memorial Sloan Kettering Cancer Center, New York, New York, United States. · University of Sheffield, Weston Park Hospital, Sheffield, United Kingdom. Electronic address: · Ramón y Cajal University Hospital, Madrid, Spain. · University of Ulm, Ulm, Germany. · Pubmed 29042085
  • UCSF Helen, Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, San Francisco, CA, 94115, USA. · Centre Léon Bérard, Lyon, France. · National Cancer Center, Goyang, Republic of Korea. · H. de Lleida Arnau de Vilanova, Lerida, Spain. · Institut de Cancérologie de l'Ouest, St Herblain-Nantes, France. · University Hospital of Parma, Parma, Italy. · Instituto Português de Oncologia Francisco Gentil, Porto, Portugal. · Korea University Medical Center, Seoul, Republic of Korea. · Ramón y Cajal University Hospital, Madrid and Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. · Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. · Merck& Co., Inc., Kenilworth, NJ, USA. · Checkmate Pharmaceuticals, Cambridge, MA, USA. · Alexion Pharmaceuticals, New Haven, CT, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 28681171
  • Department of Medicine and Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: · Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan. · Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid, Spain; Vall d'Hebron Institute of Oncology, Barcelona, Spain; Instituto Oncológico Baselga, Hospital Quirónsalud, Barcelona, Spain. · Department of Breast Oncology, Istituto Nazionale Tumouri Fondazione G Pascale, Naples, Italy. · Department of Breast Cancer, Beijing 307 Hospital of PLA, Beijing, China. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Department of Gynecology, University Hospital Schleswig-Holstein, Kiel, Germany. · Division of Medical Oncology, Ottawa Hospital Research Institute, Ottawa, ON, Canada. · Department of Radiation Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan. · Medicine Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, BC Cancer Agency, Vancouver, BC, Canada. · Department of Breast Cancer and Reconstruction Surgery, Maria Skłodowska Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland. · Department of Oncology, Ospedale di Macerata, Macerata, Italy. · Department of Surgery, Taipei Veterans General Hospital, National Yang Ming University, Taipei, Taiwan. · Division of Haematology-Oncology, Department of Medicine, University of California, Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Breast Oncology, Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan. · Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan. · Department of Medical Oncology, Université Catholique de Louvain, CHU UCL, Namur, Belgium. · Novartis Pharma SAS, Paris, France. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Syros Pharmaceuticals, Watertown, MA, USA. · Novartis Pharma AG, Basel, Switzerland. · Institut de Cancérologie de l'Ouest-René Gauducheau Centre de Recherche en Cancérologie, Nantes, France. · Pubmed 28576675
  • Memorial Sloan Kettering Cancer Center, New York, New York. · Dana-Farber Cancer Institute, Boston, Massachusetts. · University of California San Francisco Comprehensive Cancer Center, San Francisco, California. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Ramón y Cajal University Hospital, Madrid, Spain. · Institut Curie, Paris, France. · Texas Oncology, Austin, Texas. · Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, Texas. · Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center, New York, New York. · Sarah Cannon Research Institute, Tennessee Oncology PLLC, Nashville, Tennessee. · Eli Lilly and Company, Indianapolis, Indiana. · Pubmed 28533223
  • Leeds Institute of Cancer and Pathology and St James's Institute of Oncology, Leeds, UK. Electronic address: · Ramon y Cajal University Hospital, Madrid, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Baylor-Sammons Cancer Center, Texas Oncology, U.S. Oncology, Dallas, TX, USA. · Medical Oncology Clinic, Jules Bordet Institute, Brussels, Belgium. · Mayo Clinic, Jacksonville, FL, USA. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · The West Clinic, Memphis, TN, USA. · Institut Curie, Paris, France. · Sarah Cannon Research Institute, Nashville, TN, USA. · University of Minnesota, Department of Medicine, Masonic Cancer Center, Minneapolis, MN, USA. · Centre Oscar Lambret, Lille, France. · Ramon y Cajal University Hospital, Madrid, Spain. · Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. · Nektar Therapeutics, San Francisco, CA, USA. · Consultant, Sebastopol, CA, USA. · University of California, San Francisco, CA, USA. · Pubmed 28360015
  • Memorial Sloan Kettering Cancer Center, New York, NY, USA. · H. de Lleida Arnau de Vilanova, Lérida, Spain. · Institut Jules Bordet, Brussels, Belgium. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. · Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. · Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA. · Institute of Clinical Research, Odense University Hospital, University of Southern Denmark, Odense, Denmark. · Ramon y Cajal University Hospital, Madrid and Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Massachusetts General Hospital, Boston, MA, USA. · Mayo Clinic, Rochester, MN, USA. · University of Minnesota Masonic Clinical Cancer Center, Minneapolis, MN, USA. · Hospital 12 de Octubre, Madrid, Spain. · Clinique Sainte Elisabeth, Namur, Belgium. · Merck & Co., Inc., Kenilworth, NJ, USA. · Checkmate Pharmaceuticals, Cambridge, MA, USA. · UCSF Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero St., San Francisco, CA, USA. · Pubmed 28324268
  • Hospital Arnau de Vilanova, Valencia, Spain. · Hospital Universitario Ramón y Cajal, Madrid, Spain; Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Hospital Clinic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Vall d'Hebron Institute of Oncology, Barcelona, Spain; Hospital Clinic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Hospital Clínico de Valencia, Valencia, Spain. · Hospital Universitario Ramón y Cajal, Madrid, Spain. · Hospital Clinic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Hospital Universitari Vall d' Hebron, Barcelona, Spain. · Instituto Catalán de Oncología, Hospitalet, Barcelona, Spain. · Complejo Universitario de Santiago de Compostela, Santiago de Compostela, Spain. · Hospital Clinic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Molecular Oncology Laboratory, Barcelona, Spain. · Hospital Universitari Arnau Vilanova, Lleida, Spain. · Hospital Universitari Vall d' Hebron, Barcelona, Spain. · SOLTI Breast Cancer Research Group, Barcelona, Spain. · Vall d'Hebron Institute of Oncology, Barcelona, Spain; Hospital Clinic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. Electronic address: · Pubmed 28238593
  • Medical Oncology Unit, Azienda Ospedaliero-Universitaria di Parma, Via Gramsci 14, 43126, Parma, Italy. · Institut de Cancerologie de l'Ouest, René Gauducheau, Saint-Herblain, France. · Hospital Gasthuisberg, Leuven, Belgium. · Virginia Cancer Specialists, US Oncology Research, Arlington, VA, USA. · Pontificia Universidade Católica do Rio Grande do Sul School of Medicine, Porto Alegre, Brazil. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Ramon y Cajal University Hospital, Madrid, Spain. · Duke University Medical Center, Durham, NC, USA. · Moffitt Cancer Center, Tampa, FL, USA. · University of Szeged, Szeged, Hungary. · Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, Bordeaux, France. · Novartis Pharma AG, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Institut Gustave Roussy, Villejuif, France. · Pubmed 28183331
  • Breast Cancer Clinical Research Unit, CNIO - Spanish National Cancer Research Center, Madrid, Spain. · Medical Oncology Department, Hospital Clinico Universitario, Valencia, Spain. · Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain. · Medical Oncology Department, Hospital de Montepríncipe, Madrid, Spain. · Medical Oncology Department, Hospital Vall d'Hebron, Barcelona, Spain. · Medical Oncology Department, Hospital Ramón y Cajal, Madrid, Spain. · Medical Oncology Department, Hospital Clinico San Carlos, Madrid, Spain. · Medical Oncology Department, Institut Catala d'Oncologia-IDIBELL, L'Hospitalet de Llobregat, Spain. · Medical Oncology Department, MD Anderson Cancer Center, Madrid, Spain. · Medical Oncology Department, Hospital General de Albacete, Albacete, Spain. · Medical Oncology Department, Hospital Lozano Blesa, Zaragoza, Spain. · Medical Oncology Department, Institut Catala d'Oncologia-Josep Trueta, Girona, Spain. · Medical Oncology Department, Hospital Arnau de Vilanova, Valencia, Spain. · Medical Oncology Department, Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain. · Medical Oncology Department, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain. · Breast Cancer Clinical Research Unit, CNIO - Spanish National Cancer Research Center, Madrid, Spain. · GEICAM, Madrid, Spain. · Pathology Department, Hospital Ramon y Cajal, Madrid, Spain. · Molecular Imaging Unit, CNIO - Spanish National Cancer Research Center, Madrid, Spain. · Medical Oncology Department, Hospital Universitario La Princesa, Madrid, Spain. · Pubmed 27587436
  • Breast Cancer Clinical Research Unit, CNIO-Spanish National Cancer Research Center, Madrid, Spain. · Telomeres and Telomerase Group, Molecular Oncology Programme, CNIO-Spanish National Cancer Research Center, Madrid, Spain. · Medical Oncology Department, Hospital Clinico Universitario, Valencia, Spain. · Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain. · Medical Oncology Department, Hospital de Montepríncipe, Madrid, Spain. · Medical Oncology Department, Hospital Vall d´Hebron, Barcelona, Spain. · Medical Oncology Department, Hospital Ramón y Cajal, Madrid, Spain. · Medical Oncology Department, Hospital Clinico San Carlos, Madrid, Spain. · Medical Oncology Department, Institut Catala d'Oncologia-IDIBELL, L'Hospitalet de Llobregat, Spain. · Medical Oncology Department, MD Anderson Cancer Center, Madrid, Spain. · Medical Oncology Department, Hospital General de Albacete, Albacete, Spain. · Medical Oncology Department, Hospital Lozano Blesa, Zaragoza, Spain. · Medical Oncology Department, Institut Catala d'Oncologia-Hospital Dr. Josep Trueta, Girona, Spain. · Medical Oncology Department, Hospital Arnau de Vilanova, Valencia, Spain. · Medical Oncology Department, Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain. · Medical Oncology Department, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain. · GEICAM, Madrid, Spain. · Medical Oncology Department, Hospital Universitario La Princesa, Madrid, Spain. · Pubmed 28423524
  • Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Morphological Sciences Department, Universidad Autónoma de Barcelona, Spain. Electronic address: · Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Morphological Sciences Department, Universidad Autónoma de Barcelona, Spain. · Pathology Department, Virgen del Rocío University Hospital, Sevilla, Spain. · Pathology Department, Hospital Lluis Alcanys, Xàtiva, Spain. · Pathology Department, Hospital de la Ribera, Alcira, Spain. · Pathology Department, Hospital de Navarra, Pamplona, Spain. · Pathology Department, Salamanca University Hospital, Spain. · Pathology Department, Complejo Hospitalario de Jaén, Spain. · Pathology Department, Hospital Arnau de Vilanova, Lérida, Spain. · Pathology Department, Fundación Jiménez Díaz, Madrid, Spain. · Breast Cancer Unit, Vall d'Hebron University Hospital, Barcelona, Spain. · Medical Oncology Department, Baselga Institute of Oncology, Quiron Hospital, Barcelona, Spain. · Medical Oncology Department, Ramón y Cajal University Hospital, Madrid, Spain; Vall d'Hebron Oncology Institute, Barcelona, Spain. · Pubmed 28254641
  • Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain. · Hospital Provincial de Castellón, Castellón, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Pathology, Hospital Clínico Universitario de Valencia, Spain. · Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · Hospital Clínico San Cecilio, Complejo Hospitalario de Granada, Granada, Spain. · Instituto Valenciano de Oncología, Valencia, Spain. · Hospital Universitario Quirón de Madrid, Madrid, Spain. · Hospital Virgen de la Salud, Toledo, Spain. · Pathology Department, Hospital Vall d'Hebron, Barcelona, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · University of North Carolina, Chapel Hill, North Carolina. · Ramón y Cajal University Hospital, Madrid, Spain. · University of Messina, Messina, Italy. · Hospital del Mar, Barcelona, Spain. · ICREA, Barcelona, Spain. · Department of Hematology and Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Pubmed 28249905
  • University of Kansas Medical Center, Westwood, Kansas. · Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain. · Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain. · University of Kansas Medical Center, Westwood, Kansas. · Medical Oncology Department, Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú. · Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. · Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain. · Laboratory of Translational Oncology. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain. · Oncology Department, Hospital Clínico, Valladolid, Spain. · Department of Oncology, Ramon y Cajal University Hospital, Madrid, Spain. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. · Department of Pathology & Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. · Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain. · Pubmed 27301700
2016
  • Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA. · Ramon y Cajal University Hospital, Madrid, Spain. · Vall D'Hebron Institute of Oncology, Barcelona, Spain. · Baylor-Sammons Cancer Center, Texas Oncology, U.S. Oncology, Dallas, TX, USA. · Pubmed 27023712
  • Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA. · Medical Oncology Department, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Paseo Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Faculty of Medicine, Universitat Autònoma de Barcelona (UAB), Campus de la UAB, Plaza Cívica, 08193 Bellaterra, Barcelona, Spain. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA. · Ramon y Cajal University Hospital, Ctra. de Colmenar Viejo, 28034 Madrid, Spain. · Medica Scientia Innovation Research (MedSIR), C/ Rambla Catalunya 2, 2D, 08007 Barcelona, Spain. · Pubmed 27000962
  • a Department of Medical Oncology , Ramon y Cajal University Hospital , Madrid , Spain. · b Department of Medical Oncology , Vall d'Hebron Institute of Oncology , Barcelona , Spain. · Pubmed 26881332
  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain and Ramony Cajal University Hospital, Madrid, Spain. · University of California Los Angeles, Los Angeles, CA, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · MD Anderson Cancer Center, Houston, TX, USA. · Sunnybrook Odette Cancer Centre, Toronto, Canada. · Merrimack Pharmaceuticals, Inc., 1 Kendall Square, Suite B7201, Cambridge, MA, 02139-1670, USA. · Merrimack Pharmaceuticals, Inc., 1 Kendall Square, Suite B7201, Cambridge, MA, 02139-1670, USA. · Sarah Cannon Research Institute, and Tennessee Oncology, PLLC, Nashville, TN, USA. · Pubmed 27259714
  • Biochemistry Department, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas "Alberto Sols" (CSIC-UAM), IdiPAZ, Madrid, Spain. · Preclinical Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. · Pathology Department, MD Anderson Cancer Center, Madrid, Spain. · Breast Cancer and Systems Biology Unit, ProCURE, Catalan Institute of Oncology, IDIBELL, L'Hospitalet del Llobregat, Barcelona, Spain. · Translational Research Laboratory, MD Anderson Internacional Foundation, Madrid, Spain. · Cytogenetics Department, MD Anderson Cancer Center, Madrid, Spain. · Pathology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain. · Oncology Department, MD Anderson Cancer Center, Madrid, Spain. · Clinical Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autonoma de Barcelona, Barcelona, Spain. · Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Molecular Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. · Pathology Department, Hospital Vall d'Hebron University, Barcelona, Spain. · Pathology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Pubmed 27462779
  • Breast Surgical Oncology Unit, Hospital Universitario Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · Pathology Department, Hospital Universitario Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Medical Oncology, Hospital Universitario Vall d'Hebron, Barcelona, Spain. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Breast Surgical Oncology Unit, Hospital Universitario Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · Pubmed 27357178
2015
  • Vall d'Hebron Institute of Oncology, Barcelona, Spain and Ramon y Cajal University Hospital, Madrid, Spain. Electronic address: · Institut Curie, Paris, France. · National Cancer Center, Goyang-si, Republic of Korea. · Centre Antoine Lacassagne, Nice, France. · Centre Léon Bérard, Lyon, France. · University of California, Los Angeles, CA, USA. · Centre Oscar Lambret, Lille, France; University Hospital, Lille, France. · Hôpital Saint-Louis, Paris, France. · Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · National Center for Tumor Diseases, University Hospital, Heidelberg, Germany. · Severance Hospital, Sinchon-dong, Seodaemun-gu, Seoul, South Korea. · Centre Jean Perrin, Clermont-Ferrand, France. · Tampere University Hospital and University of Tampere, Tampere, Finland. · Sansum Clinic, Santa Barbara, CA, USA. · Università di Modena e Reggio Emilia, Modena, Italy. · Hospital Universitario 12 de Octubre, Madrid, Spain. · Comprehensive Cancer Center, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland. · Boehringer Ingelheim, Paris, France. · Boehringer Ingelheim, Reims, France. · Pubmed 26596672
  • Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Oncology Department, Ramon y Cajal University Hospital, Madrid, Spain. · Department of Quantitative Science, Clinical Outcomes Solutions, 3709 North Campbell, Tucson, AZ, USA. · Department of Oncology, Leeds Institute of Cancer and Pathology, and St James's Institute of Oncology, University of Leeds, Leeds, LS9 7TF, England, UK. · Division of Hematology/Oncology, Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA. · Medical Oncology Clinic, Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, University of Montreal, Montreal, QC, Canada. · Formerly of Eisai Ltd, Hatfield, England, UK. · Section of Hematology/Oncology, Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA. · Department of Global Value and Access Strategy, Eisai Inc., Woodcliff Lake, NJ, USA. · Department of Oncology, Leeds Institute of Cancer and Pathology, and St James's Institute of Oncology, University of Leeds, Leeds, LS9 7TF, England, UK. · Pubmed 26567010
  • Mayo Clinic, Jacksonville, FL, USA. Electronic address: · Medical Oncology Clinic, Jules Bordet Institute, Brussels, Belgium. · Baylor-Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. · University of California, San Francisco, CA, USA. · University of Leeds and St James's University Hospital, Leeds, UK. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · The West Clinic, Memphis, TN, USA. · Institut Curie, Paris, France. · Sarah Cannon Research Institute, Nashville, TN, USA. · University of Minnesota Department of Medicine and Masonic Cancer Center, Minneapolis, MN, USA. · Centre Oscar Lambret, Lille, France. · Mayo Clinic, Jacksonville, FL, USA. · Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. · Nektar Therapeutics, San Francisco, CA, USA. · Sebastopol, CA, USA. · Vall d'Hebron Institute of Oncology, Barcelona, Spain; Ramon y Cajal University Hospital, Madrid, Spain. · Pubmed 26482278
  • Section of Oncology and Clinical Research, Leeds Institute of Cancer and Pathology, University of Leeds and Leeds Teaching Hospitals Trust, Leeds, UK. · St James' Institute of Oncology, St James' University Hospital, University of Leeds, Bexley Wing, Level 4, Beckett Street, Leeds, UK. · Department of Oncology, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Department of Oncology, Ramon y Cajal University Hospital, Madrid, Spain. · Section of Hematology/Oncology, Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA. · Department of Medicine, University of Montreal, Montreal, QC, Canada. · Medical Oncology Clinic, Medicine Department, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. · Oncology Imaging, Eisai Inc., Woodcliff Lake, NJ, USA. · Oncology PCU, Clinical Development, Eisai Inc., Woodcliff Lake, NJ, USA. · Department of Medical Affairs, Eisai Inc., Woodcliff Lake, NJ, USA. · Department of Medical Oncology, US Oncology, Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX, USA. · Section of Oncology and Clinical Research, Leeds Institute of Cancer and Pathology, University of Leeds and Leeds Teaching Hospitals Trust, Leeds, UK. · Division of Hematology/Oncology, Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA. · Pubmed 27391598
  • Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain. · Oncology Experimental Therapeutics Unit, IRCCS Humanitas Clinical and Research Institute, Rozzano, Milan, Italy. · Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Division of Pathology, IRCCS Humanitas Clinical and Research Institute, Rozzano, Milan, Italy, University of Milan, Milan, Italy. · Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands. · Cancer Pharmacology Laboratory, AIRC Start-Up Unit, University of Pisa, Pisa, Italy. · Pathology Department, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain. · Division of Oncology and Hematology, IRCCS Humanitas Clinical and Research Institute, Rozzano, Milan, Italy. · Deparment of Clinical and Biomedical Sciences "Luigi Sacco", University of Milan, Milan, Italy. · Ramon y Cajal University Hospital, Madrid, Spain. · Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. · Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 26452030
Probable:    Miscellaneous institutions in Madrid      
2017
  • Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain. · Hospital Provincial de Castellón, Castellón, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Pathology, Hospital Clínico Universitario de Valencia, Spain. · Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · Hospital Clínico San Cecilio, Complejo Hospitalario de Granada, Granada, Spain. · Instituto Valenciano de Oncología, Valencia, Spain. · Hospital Universitario Quirón de Madrid, Madrid, Spain. · Hospital Virgen de la Salud, Toledo, Spain. · Pathology Department, Hospital Vall d'Hebron, Barcelona, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · University of North Carolina, Chapel Hill, North Carolina. · Ramón y Cajal University Hospital, Madrid, Spain. · University of Messina, Messina, Italy. · Hospital del Mar, Barcelona, Spain. · ICREA, Barcelona, Spain. · Department of Hematology and Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Pubmed 28249905
2016
  • Medical Oncology Department, MD Anderson Cancer Center, Madrid, C/ Arturo Soria, 270, 28033 - Madrid. Spain. · Pubmed 26278712
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 116 total) written by Javier Cortes about Breast Neoplasms:

  • Ongoing unmet needs in treating estrogen receptor-positive/HER2-negative metastatic breast cancer. 2018
  • Long-term efficacy analysis of the randomised, phase II TRYPHAENA cardiac safety study: Evaluating pertuzumab and trastuzumab plus standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer. 2018
  • The next era of treatment for hormone receptor-positive, HER2-negative advanced breast cancer: Triplet combination-based endocrine therapies. 2017
  • Tumor-infiltrating lymphocytes in Breast Cancer and implications for clinical practice. 2017
  • Advances in the management of HER2-positive early breast cancer. 2017
  • A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer. 2017
  • Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial. 2017
  • MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR 2017
  • Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial. 2017
  • A phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancer. 2017
Show List of Full Article Records
Google Searches

Learn more about Javier Cortes using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Universitat Autonoma de Barcelona
Hospital Ramon y Cajal
Miscellaneous institutions in Madrid
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Universitat Autonoma de Barcelona
2018
  • Department of Medical Oncology, Acıbadem University School of Medicine, Istanbul, Turkey. Electronic address: · Cancer Research UK Clinical Centre, St James' University Hospital, Leeds, UK. Electronic address: · Center Eugène Marquis, Rennes, France. Electronic address: · Medical Oncology Department, Ramon y Cajal University Hospital, Madrid, Spain; Medical Oncology Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Electronic address: · Medical Oncology Clinic, Institut Jules Bordet Universite Libre de Bruxelles, Brussels, Belgium. Electronic address: · Pubmed 29329006
  • National Center for Tumor Diseases, University Hospital, Heidelberg, Germany. Electronic address: · British Columbia Cancer Agency - Vancouver Centre, University of British Columbia, Vancouver, Canada. · Royal Bournemouth Hospital, Bournemouth University, Bournemouth, UK. · Regional Cancer and Blood Services, Auckland City Hospital, Auckland, New Zealand. · Cancer Institute "Ion Chiricuta", Cluj-Napoca, Romania. · Clinical Science, Global Product Development, Roche Products Limited, Welwyn Garden City, UK. · Product Development - Oncology, Genentech, Inc., South San Francisco, CA, USA. · PDBB - Biostatistics, Roche Products Limited, Welwyn Garden City, UK. · Ramón y Cajal University Hospital, Madrid and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Pubmed 29223479
2017
  • Ramón y Cajal University Hospital, Carretera de Colmenar Viejo, 9.100, 28034 Madrid, Spain; Vall d'Hebron Institute of Oncology, Psg. Vall d'Hebron 119-129, Barcelona, Spain. Electronic address: · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, 101 Daehak-ro, Jongro-gu, Seoul, Republic of Korea. · Ramón y Cajal University Hospital, Carretera de Colmenar Viejo, 9.100, 28034 Madrid, Spain; Baselga Institute of Oncology, Ruber & San Camilo Hospitals, Madrid, Spain. · Baselga Institute of Oncology, Hospital Quiron, Plaza Alfonso Comín, 5, Barcelona, Spain. · Barts Cancer Institute, Queen Mary University of London, Old Anatomy Building, Ashfield Street, London, UK. · MD Anderson Cancer Center, University of Texas, 1515 Holcombe Blvd, Houston 77030, TX, USA. · Pubmed 29100169
  • Hospital Sirio Libanes, Adma Jafet St 91, 1308050 São Paulo, Brazil. · Ramon y Cajal University Hospital, Ctra. Colmenar Viejo km. 9, 100, 28034 Madrid, Spain; Vall d'Hebron Institute of Oncology, Centro Cellex, Calle Natzaret 115-117, 08035 Barcelona, Spain. Electronic address: · European Institute of Oncology, Via Ripamonti 435, 20146 Milano, Italy. Electronic address: · Peter MacCallum Cancer Centre, University of Melbourne, Grattan Street 305, 3000 Melbourne, Australia. Electronic address: · Institute of Pathology, Charité Universitätsmedizin Berlin and German Cancer Consortium (DKTK), Campus Mitte, Charitéplatz 1, D-10117 Berlin, Germany. Electronic address: · Baselga Oncological Institute, Quiron Hospital, Plaça d'Alfonso Comín 5, 08023 Barcelona, Spain. Electronic address: · Ramon y Cajal University Hospital, Ctra. Colmenar Viejo km. 9, 100, 28034 Madrid, Spain; Baselga Institute of Oncology, Madrid, Spain. Electronic address: · Pubmed 29061314
  • UCSF Helen, Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, San Francisco, CA, 94115, USA. · Centre Léon Bérard, Lyon, France. · National Cancer Center, Goyang, Republic of Korea. · H. de Lleida Arnau de Vilanova, Lerida, Spain. · Institut de Cancérologie de l'Ouest, St Herblain-Nantes, France. · University Hospital of Parma, Parma, Italy. · Instituto Português de Oncologia Francisco Gentil, Porto, Portugal. · Korea University Medical Center, Seoul, Republic of Korea. · Ramón y Cajal University Hospital, Madrid and Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. · Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. · Merck& Co., Inc., Kenilworth, NJ, USA. · Checkmate Pharmaceuticals, Cambridge, MA, USA. · Alexion Pharmaceuticals, New Haven, CT, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 28681171
  • Department of Medicine and Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: · Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan. · Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid, Spain; Vall d'Hebron Institute of Oncology, Barcelona, Spain; Instituto Oncológico Baselga, Hospital Quirónsalud, Barcelona, Spain. · Department of Breast Oncology, Istituto Nazionale Tumouri Fondazione G Pascale, Naples, Italy. · Department of Breast Cancer, Beijing 307 Hospital of PLA, Beijing, China. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Department of Gynecology, University Hospital Schleswig-Holstein, Kiel, Germany. · Division of Medical Oncology, Ottawa Hospital Research Institute, Ottawa, ON, Canada. · Department of Radiation Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan. · Medicine Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, BC Cancer Agency, Vancouver, BC, Canada. · Department of Breast Cancer and Reconstruction Surgery, Maria Skłodowska Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland. · Department of Oncology, Ospedale di Macerata, Macerata, Italy. · Department of Surgery, Taipei Veterans General Hospital, National Yang Ming University, Taipei, Taiwan. · Division of Haematology-Oncology, Department of Medicine, University of California, Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Breast Oncology, Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan. · Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan. · Department of Medical Oncology, Université Catholique de Louvain, CHU UCL, Namur, Belgium. · Novartis Pharma SAS, Paris, France. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Syros Pharmaceuticals, Watertown, MA, USA. · Novartis Pharma AG, Basel, Switzerland. · Institut de Cancérologie de l'Ouest-René Gauducheau Centre de Recherche en Cancérologie, Nantes, France. · Pubmed 28576675
  • Leeds Institute of Cancer and Pathology and St James's Institute of Oncology, Leeds, UK. Electronic address: · Ramon y Cajal University Hospital, Madrid, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Baylor-Sammons Cancer Center, Texas Oncology, U.S. Oncology, Dallas, TX, USA. · Medical Oncology Clinic, Jules Bordet Institute, Brussels, Belgium. · Mayo Clinic, Jacksonville, FL, USA. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · The West Clinic, Memphis, TN, USA. · Institut Curie, Paris, France. · Sarah Cannon Research Institute, Nashville, TN, USA. · University of Minnesota, Department of Medicine, Masonic Cancer Center, Minneapolis, MN, USA. · Centre Oscar Lambret, Lille, France. · Ramon y Cajal University Hospital, Madrid, Spain. · Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. · Nektar Therapeutics, San Francisco, CA, USA. · Consultant, Sebastopol, CA, USA. · University of California, San Francisco, CA, USA. · Pubmed 28360015
  • Memorial Sloan Kettering Cancer Center, New York, NY, USA. · H. de Lleida Arnau de Vilanova, Lérida, Spain. · Institut Jules Bordet, Brussels, Belgium. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. · Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. · Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA. · Institute of Clinical Research, Odense University Hospital, University of Southern Denmark, Odense, Denmark. · Ramon y Cajal University Hospital, Madrid and Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Massachusetts General Hospital, Boston, MA, USA. · Mayo Clinic, Rochester, MN, USA. · University of Minnesota Masonic Clinical Cancer Center, Minneapolis, MN, USA. · Hospital 12 de Octubre, Madrid, Spain. · Clinique Sainte Elisabeth, Namur, Belgium. · Merck & Co., Inc., Kenilworth, NJ, USA. · Checkmate Pharmaceuticals, Cambridge, MA, USA. · UCSF Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero St., San Francisco, CA, USA. · Pubmed 28324268
  • Hospital Arnau de Vilanova, Valencia, Spain. · Hospital Universitario Ramón y Cajal, Madrid, Spain; Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Hospital Clinic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Vall d'Hebron Institute of Oncology, Barcelona, Spain; Hospital Clinic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Hospital Clínico de Valencia, Valencia, Spain. · Hospital Universitario Ramón y Cajal, Madrid, Spain. · Hospital Clinic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Hospital Universitari Vall d' Hebron, Barcelona, Spain. · Instituto Catalán de Oncología, Hospitalet, Barcelona, Spain. · Complejo Universitario de Santiago de Compostela, Santiago de Compostela, Spain. · Hospital Clinic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Molecular Oncology Laboratory, Barcelona, Spain. · Hospital Universitari Arnau Vilanova, Lleida, Spain. · Hospital Universitari Vall d' Hebron, Barcelona, Spain. · SOLTI Breast Cancer Research Group, Barcelona, Spain. · Vall d'Hebron Institute of Oncology, Barcelona, Spain; Hospital Clinic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. Electronic address: · Pubmed 28238593
  • Breast Cancer Clinical Research Unit, CNIO - Spanish National Cancer Research Center, Madrid, Spain. · Medical Oncology Department, Hospital Clinico Universitario, Valencia, Spain. · Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain. · Medical Oncology Department, Hospital de Montepríncipe, Madrid, Spain. · Medical Oncology Department, Hospital Vall d'Hebron, Barcelona, Spain. · Medical Oncology Department, Hospital Ramón y Cajal, Madrid, Spain. · Medical Oncology Department, Hospital Clinico San Carlos, Madrid, Spain. · Medical Oncology Department, Institut Catala d'Oncologia-IDIBELL, L'Hospitalet de Llobregat, Spain. · Medical Oncology Department, MD Anderson Cancer Center, Madrid, Spain. · Medical Oncology Department, Hospital General de Albacete, Albacete, Spain. · Medical Oncology Department, Hospital Lozano Blesa, Zaragoza, Spain. · Medical Oncology Department, Institut Catala d'Oncologia-Josep Trueta, Girona, Spain. · Medical Oncology Department, Hospital Arnau de Vilanova, Valencia, Spain. · Medical Oncology Department, Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain. · Medical Oncology Department, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain. · Breast Cancer Clinical Research Unit, CNIO - Spanish National Cancer Research Center, Madrid, Spain. · GEICAM, Madrid, Spain. · Pathology Department, Hospital Ramon y Cajal, Madrid, Spain. · Molecular Imaging Unit, CNIO - Spanish National Cancer Research Center, Madrid, Spain. · Medical Oncology Department, Hospital Universitario La Princesa, Madrid, Spain. · Pubmed 27587436
  • Breast Cancer Clinical Research Unit, CNIO-Spanish National Cancer Research Center, Madrid, Spain. · Telomeres and Telomerase Group, Molecular Oncology Programme, CNIO-Spanish National Cancer Research Center, Madrid, Spain. · Medical Oncology Department, Hospital Clinico Universitario, Valencia, Spain. · Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain. · Medical Oncology Department, Hospital de Montepríncipe, Madrid, Spain. · Medical Oncology Department, Hospital Vall d´Hebron, Barcelona, Spain. · Medical Oncology Department, Hospital Ramón y Cajal, Madrid, Spain. · Medical Oncology Department, Hospital Clinico San Carlos, Madrid, Spain. · Medical Oncology Department, Institut Catala d'Oncologia-IDIBELL, L'Hospitalet de Llobregat, Spain. · Medical Oncology Department, MD Anderson Cancer Center, Madrid, Spain. · Medical Oncology Department, Hospital General de Albacete, Albacete, Spain. · Medical Oncology Department, Hospital Lozano Blesa, Zaragoza, Spain. · Medical Oncology Department, Institut Catala d'Oncologia-Hospital Dr. Josep Trueta, Girona, Spain. · Medical Oncology Department, Hospital Arnau de Vilanova, Valencia, Spain. · Medical Oncology Department, Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain. · Medical Oncology Department, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain. · GEICAM, Madrid, Spain. · Medical Oncology Department, Hospital Universitario La Princesa, Madrid, Spain. · Pubmed 28423524
  • Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Morphological Sciences Department, Universidad Autónoma de Barcelona, Spain. Electronic address: · Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Morphological Sciences Department, Universidad Autónoma de Barcelona, Spain. · Pathology Department, Virgen del Rocío University Hospital, Sevilla, Spain. · Pathology Department, Hospital Lluis Alcanys, Xàtiva, Spain. · Pathology Department, Hospital de la Ribera, Alcira, Spain. · Pathology Department, Hospital de Navarra, Pamplona, Spain. · Pathology Department, Salamanca University Hospital, Spain. · Pathology Department, Complejo Hospitalario de Jaén, Spain. · Pathology Department, Hospital Arnau de Vilanova, Lérida, Spain. · Pathology Department, Fundación Jiménez Díaz, Madrid, Spain. · Breast Cancer Unit, Vall d'Hebron University Hospital, Barcelona, Spain. · Medical Oncology Department, Baselga Institute of Oncology, Quiron Hospital, Barcelona, Spain. · Medical Oncology Department, Ramón y Cajal University Hospital, Madrid, Spain; Vall d'Hebron Oncology Institute, Barcelona, Spain. · Pubmed 28254641
2016
  • Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA. · Medical Oncology Department, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Paseo Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Faculty of Medicine, Universitat Autònoma de Barcelona (UAB), Campus de la UAB, Plaza Cívica, 08193 Bellaterra, Barcelona, Spain. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA. · Ramon y Cajal University Hospital, Ctra. de Colmenar Viejo, 28034 Madrid, Spain. · Medica Scientia Innovation Research (MedSIR), C/ Rambla Catalunya 2, 2D, 08007 Barcelona, Spain. · Pubmed 27000962
  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain and Ramony Cajal University Hospital, Madrid, Spain. · University of California Los Angeles, Los Angeles, CA, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · MD Anderson Cancer Center, Houston, TX, USA. · Sunnybrook Odette Cancer Centre, Toronto, Canada. · Merrimack Pharmaceuticals, Inc., 1 Kendall Square, Suite B7201, Cambridge, MA, 02139-1670, USA. · Merrimack Pharmaceuticals, Inc., 1 Kendall Square, Suite B7201, Cambridge, MA, 02139-1670, USA. · Sarah Cannon Research Institute, and Tennessee Oncology, PLLC, Nashville, TN, USA. · Pubmed 27259714
  • Biochemistry Department, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas "Alberto Sols" (CSIC-UAM), IdiPAZ, Madrid, Spain. · Preclinical Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. · Pathology Department, MD Anderson Cancer Center, Madrid, Spain. · Breast Cancer and Systems Biology Unit, ProCURE, Catalan Institute of Oncology, IDIBELL, L'Hospitalet del Llobregat, Barcelona, Spain. · Translational Research Laboratory, MD Anderson Internacional Foundation, Madrid, Spain. · Cytogenetics Department, MD Anderson Cancer Center, Madrid, Spain. · Pathology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain. · Oncology Department, MD Anderson Cancer Center, Madrid, Spain. · Clinical Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autonoma de Barcelona, Barcelona, Spain. · Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Molecular Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. · Pathology Department, Hospital Vall d'Hebron University, Barcelona, Spain. · Pathology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Pubmed 27462779
  • Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Universitat Autònoma de Barcelona, Plaça Cívica, 08193 Bellaterra (Cerdanyola del Vallès), Spain. · OncoPlex Diagnostics (Division of NantOmics, LLC), 9600 Medical Center Drive, Suite 300, Rockville, MD 20850, USA. · Department of Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Department of Pathology, Vall d'Hebron University Hospital, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Preclinical Research Program, Vall d'Hebron Institute of Oncology, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain. · Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Pubmed 26422389
2015
  • Vall d'Hebron Institute of Oncology, Barcelona, Spain and Ramon y Cajal University Hospital, Madrid, Spain. Electronic address: · Institut Curie, Paris, France. · National Cancer Center, Goyang-si, Republic of Korea. · Centre Antoine Lacassagne, Nice, France. · Centre Léon Bérard, Lyon, France. · University of California, Los Angeles, CA, USA. · Centre Oscar Lambret, Lille, France; University Hospital, Lille, France. · Hôpital Saint-Louis, Paris, France. · Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · National Center for Tumor Diseases, University Hospital, Heidelberg, Germany. · Severance Hospital, Sinchon-dong, Seodaemun-gu, Seoul, South Korea. · Centre Jean Perrin, Clermont-Ferrand, France. · Tampere University Hospital and University of Tampere, Tampere, Finland. · Sansum Clinic, Santa Barbara, CA, USA. · Università di Modena e Reggio Emilia, Modena, Italy. · Hospital Universitario 12 de Octubre, Madrid, Spain. · Comprehensive Cancer Center, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland. · Boehringer Ingelheim, Paris, France. · Boehringer Ingelheim, Reims, France. · Pubmed 26596672
  • Mayo Clinic, Jacksonville, FL, USA. Electronic address: · Medical Oncology Clinic, Jules Bordet Institute, Brussels, Belgium. · Baylor-Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. · University of California, San Francisco, CA, USA. · University of Leeds and St James's University Hospital, Leeds, UK. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · The West Clinic, Memphis, TN, USA. · Institut Curie, Paris, France. · Sarah Cannon Research Institute, Nashville, TN, USA. · University of Minnesota Department of Medicine and Masonic Cancer Center, Minneapolis, MN, USA. · Centre Oscar Lambret, Lille, France. · Mayo Clinic, Jacksonville, FL, USA. · Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. · Nektar Therapeutics, San Francisco, CA, USA. · Sebastopol, CA, USA. · Vall d'Hebron Institute of Oncology, Barcelona, Spain; Ramon y Cajal University Hospital, Madrid, Spain. · Pubmed 26482278
  • Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, P. Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA. · Universitat Autònoma de Barcelona, 08193 Barcelona, Spain. · Vall d'Hebron Institute of Research, Vall d'Hebron University Hospital, Ps Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. · Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Quirón Dexeus University Hospital, 08028 Barcelona, Spain. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Pubmed 26554728
  • Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain. · Oncology Experimental Therapeutics Unit, IRCCS Humanitas Clinical and Research Institute, Rozzano, Milan, Italy. · Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Division of Pathology, IRCCS Humanitas Clinical and Research Institute, Rozzano, Milan, Italy, University of Milan, Milan, Italy. · Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands. · Cancer Pharmacology Laboratory, AIRC Start-Up Unit, University of Pisa, Pisa, Italy. · Pathology Department, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain. · Division of Oncology and Hematology, IRCCS Humanitas Clinical and Research Institute, Rozzano, Milan, Italy. · Deparment of Clinical and Biomedical Sciences "Luigi Sacco", University of Milan, Milan, Italy. · Ramon y Cajal University Hospital, Madrid, Spain. · Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. · Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 26452030
  • Preclinical Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, 08035, Barcelona, Spain; Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Campus de la UAB, 08193, Bellaterra, Spain. · Pathology Department, Vall d'Hebron University Hospital, 08035, Barcelona, Spain. · Preclinical Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, 08035, Barcelona, Spain. · Molecular Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, 08035, Barcelona, Spain. · Pathology Department, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, 46010, Valencia, Spain. · Oncology Department, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, 46010, Valencia, Spain. · Clinical Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, 08035, Barcelona, Spain. · Translational Research Department, Institut Curie, 75005, Paris, France. · Novartis Oncology Translational Research, Cambridge, MA, 02139, United States of America. · Novartis Pharma AG, Postfach, CH-4002, Basel, Switzerland. · Preclinical Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, 08035, Barcelona, Spain; Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Campus de la UAB, 08193, Bellaterra, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010, Barcelona, Spain. · Pubmed 26075403
  • University of Leeds and St James' Institute of Oncology, Leeds, United Kingdom · St James' Institute of Oncology, Leeds, United Kingdom. · Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Pubmed 25732168
2014
  • Breast Cancer Unit, Vall d׳Hebron Institute of Oncology, Vall d׳Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain. · Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY. Electronic address: · Pubmed 25440604
  • German Breast Group, Neu-Isenburg, and University Women's Hospital, Frankfurt, Germany. Electronic address: · University Hospital of Udine, Udine, Italy. · Vall d'Hebron Institute of Oncology and Vall d'Hebron University Hospital, Barcelona, Spain. · Center of Oncology, University Hospital Split, Split, Croatia. · Outpatient Cancer Center, Freiburg, Germany. · Department of Medicine I and Comprehensive Cancer Center, Medical University Vienna, Vienna, Austria; Central European Cooperative Oncology Group, Vienna, Austria. · Centre Hospitalier-Universitaire de Besançon, Besançon, France. · Institut du Cancer Montpellier, Val d'Aurelle, France. · National Institute of Oncology, Budapest, Hungary. · Hospital Universitario 12 Octubre, Madrid, Spain. · Istituto Nazionale Tumori Fondazione G Pascale, Naples, Italy. · Centre Henri Becquerel, Rouen, France. · F Hoffmann-La Roche Ltd, Basel, Switzerland. · Assistance-Publique Hôpitaux de Paris-Tenon, Institut Universitaire de Cancerologie Université Pierre et Marie Curie, Sorbonne Université, Paris, France. · Pubmed 25273342
  • Medica Scientia Innovation Research (MedSIR ARO), Barcelona, Spain; Hospital Arnau de Vilanova de Valencia, Valencia, Spain. Electronic address: · Institut Regional du Cancer en Franche-Comté, Centre Hospitalier Universitaire de Besançon, Besançon, France. · Sandro Pitigliani Medical Oncology Department, Nuovo Ospedale di Prato, Istituto Toscano Tumori, Prato, Italy. · University Hospital 12 de Octubre, Madrid, Spain. · Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada. · Institut Curie, Université Paris Descartes, Paris, France. · Royal Marsden Hospital and The Institute of Cancer Research, London, UK. · Department of Gynaecology, Martin-Luther-Universität Halle-Wittenberg, Halle an der Saale, Germany. · F Hoffmann-La Roche Ltd, Basel, Switzerland. · Medica Scientia Innovation Research (MedSIR ARO), Barcelona, Spain; Scienco Klinico, Barcelona, Spain. · Medica Scientia Innovation Research (MedSIR ARO), Barcelona, Spain; Vall d'Hebron University Hospital, Barcelona, Spain. · Pubmed 25047747
  • Breast Surgical Unit, Breast Cancer Center, Vall d'Hebron Instituto de Oncología. Hospital Universitario Vall d'Hebron. Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address: · Department of Pathology, Vall d'Hebron Instituto de Oncología. Hospital Universitario Vall d'Hebron. Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Radiation Oncology, Vall d'Hebron Instituto de Oncología. Hospital Universitario Vall d'Hebron. Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Medical Oncology, Breast Cancer Center, Vall d'Hebron Instituto de Oncología. Hospital Universitario Vall d'Hebron. Universitat Autònoma de Barcelona, Barcelona, Spain. · Breast Surgical Unit, Breast Cancer Center, Vall d'Hebron Instituto de Oncología. Hospital Universitario Vall d'Hebron. Universitat Autònoma de Barcelona, Barcelona, Spain. · Pubmed 24703804
  • *Authors contributed equally to this work. · *Authors contributed equally to this work.Affiliations of authors: Preclinical Research (JLPP, BM, ME, RV, MZF, KP, VS, AP, JA) and Clinical Research Programs (PN, JC, ITR), Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain (VP); Human Oncology and Pathogenesis Program (HOPP) and Memorial Sloan Kettering Cancer Center, New York, NY (MS, JB); Instituto de Biología Molecular y Celular del Cáncer, Campus Miguel de Unamuno, Salamanca, Spain (AP); Lineberger Comprehensive Cancer Center, Chapel Hill, NC (CMP); Department of Biochemistry and Molecular Biology, Universitat Autonoma de Barcelona, Campus de la UAB, Bellaterra, Spain (JA); Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (JA). · Pubmed 25253614
  • Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Medical Oncology, Institut Curie, Paris, France. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain. · Universitat Autònoma de Barcelona, Barcelona, Spain; Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain. · Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; Universitat Autònoma de Barcelona, Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. Electronic address: · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. Electronic address: · Pubmed 24220311
2012
  • Breast Cancer Program, Department of Oncology, Vall d'Hebron University Hospital, Vall d'Hebron 119-129, Barcelona, Spain. · Pubmed 22113255
  • Department of Oncology, Vall d'Hebron University Hospital, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Pubmed 21872996
  • Department of Oncology, Vall d´Hebron University Hospital, Barcelona, Spain. · Pubmed 21550727
  • Department of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain. · Pubmed 22196033
  • Department of Oncology, Vall d'Hebron University Hospital, P° Vall d'Hebron 129-139, 08035 Barcelona, Spain; · Pubmed 22927522
2011
  • Vall d'Hebron University Hospital, Oncology Department, Breast Cancer Unit, Paseo Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Pubmed 21151204
  • Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Pubmed 21376385
  • Department of Medical Oncology, Breast Cancer Unit, Vall d'Hebron University Hospital, 08035 Barcelona, Spain. · Pubmed 21375468
2010
2014
  • José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY; Javier Cortés, Vall d'Hebron University Hospital, Barcelona, Spain; Seock-Ah Im, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Emma Clark and Graham Ross, Roche Products, Welwyn Garden City, United Kingdom; Astrid Kiermaier, F. Hoffmann-La Roche, Basel, Switzerland; and Sandra M. Swain, Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC. · José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY; Javier Cortés, Vall d'Hebron University Hospital, Barcelona, Spain; Seock-Ah Im, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Emma Clark and Graham Ross, Roche Products, Welwyn Garden City, United Kingdom; Astrid Kiermaier, F. Hoffmann-La Roche, Basel, Switzerland; and Sandra M. Swain, Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC. · Pubmed 25332247
  • Cristina Saura and Javier Cortés, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona; Jose A. Garcia-Saenz, Hospital Clinico San Carlos; Miguel Martin, Hospital Gregorio Maranon, Universidad Complutense, Madrid, Spain; Binghe Xu, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China; Wael Harb, Horizon Medical Group, Lafayette, IN; Rebecca Moroose, University of Florida Health Cancer Center, Orlando, FL; Timothy Pluard, Washington University School of Medicine, St Louis, MO; Corinne Kiger, Pfizer Global Research and Development, Paris; Caroline Germa, Novartis Pharma, Rueil-Malmaison, France; Kongming Wang, Pfizer, Pearl River; José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY; and Sung-Bae Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · Cristina Saura and Javier Cortés, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona; Jose A. Garcia-Saenz, Hospital Clinico San Carlos; Miguel Martin, Hospital Gregorio Maranon, Universidad Complutense, Madrid, Spain; Binghe Xu, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China; Wael Harb, Horizon Medical Group, Lafayette, IN; Rebecca Moroose, University of Florida Health Cancer Center, Orlando, FL; Timothy Pluard, Washington University School of Medicine, St Louis, MO; Corinne Kiger, Pfizer Global Research and Development, Paris; Caroline Germa, Novartis Pharma, Rueil-Malmaison, France; Kongming Wang, Pfizer, Pearl River; José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY; and Sung-Bae Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · Pubmed 25287822
  • University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain; Weill Cornell Medical College, New York, New York, USA; Jules Bordet Institute, Brussels, Belgium; University of Leeds and St James's Institute of Oncology, Leeds, UK; Formerly of Eisai Ltd, Hatfield, UK; Eisai Inc., Woodcliff Lake, New Jersey, USA; NJS Associates Company, Somerset, New Jersey USA; Baylor-Charles A. Sammons Cancer Center, Texas Oncology, and US Oncology, Dallas, Texas, USA. · Pubmed 24682463
2013
  • Medical Oncology Department, Vall d'Hebron Institute of Oncology, Vall D'Hebron University Hospital, Barcelona, Spain. · Pubmed 23881722
  • Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Paseo Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Pubmed 23712187
  • aVall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain bMedStar Washington Hospital Center, Washington Cancer Institute, Washington, District of Columbia cMid Ohio Oncology/Hematology Inc., The Mark H. Zangmeister Center, Columbus, Ohio dGenentech, South San Francisco, California eMemorial Sloan-Kettering Cancer Center, New York, New York, USA fRiga East University Hospital Oncology Center, Riga, Latvia gDaugavpils Reǵionālā Slimnīca, Daugavpils, Latvia hGesundheitszentrum Fricktal, Spital Rheinfelden & Laufenburg, Rheinfelden, Switzerland iNational Hospital Organization Osaka National Hospital, Osaka-City, Osaka, Japan jRoche Products Limited, Welwyn Garden City, UK kPharsight, Montreal, Quebec, Canada. · Pubmed 23969513
  • Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain. · Pubmed 23932547
  • From the Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Medica Scientia Innovation Research (MedSIR), Passeig Vall d'Hebron, Barcelona, Spain. · Pubmed 23714447
  • Breast Cancer Center, Vall d'Hebron University Hospital, Passeig de la Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Pubmed 23137566
  • Vall d'Hebron Breast Cancer Center, Service of Gynecology, Hospital Universitari Vall d'Hebron, Barcelona, Spain. · Pubmed 23116970
  • Affiliations of authors: Department of Oncology, IRCCS Fondazione Istituto Nazionale dei Tumori, Milano, Italy (SDC); Department of Oncology (LdM, JC), and Beast Cancer Surgery (IR), Vall d'Hebron University Hospital, Barcelona, Spain. · Pubmed 24218522
2012
  • Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain. · Pubmed 22523199
  • Medical Oncology Department, Vall D'Hebron University Hospital, Paseo Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Pubmed 22560618
  • Breast Cancer Unit, Service of Gynecology, Hospital Vall d'Hebron, Barcelona, Spain. · Pubmed 22018510
2010
  • Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Paseo Vall d'Hebron 119-129, Barcelona, Spain E-08035. · Pubmed 20124182
Hospital Ramon y Cajal
2018
  • Department of Medical Oncology, Acıbadem University School of Medicine, Istanbul, Turkey. Electronic address: · Cancer Research UK Clinical Centre, St James' University Hospital, Leeds, UK. Electronic address: · Center Eugène Marquis, Rennes, France. Electronic address: · Medical Oncology Department, Ramon y Cajal University Hospital, Madrid, Spain; Medical Oncology Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Electronic address: · Medical Oncology Clinic, Institut Jules Bordet Universite Libre de Bruxelles, Brussels, Belgium. Electronic address: · Pubmed 29329006
  • National Center for Tumor Diseases, University Hospital, Heidelberg, Germany. Electronic address: · British Columbia Cancer Agency - Vancouver Centre, University of British Columbia, Vancouver, Canada. · Royal Bournemouth Hospital, Bournemouth University, Bournemouth, UK. · Regional Cancer and Blood Services, Auckland City Hospital, Auckland, New Zealand. · Cancer Institute "Ion Chiricuta", Cluj-Napoca, Romania. · Clinical Science, Global Product Development, Roche Products Limited, Welwyn Garden City, UK. · Product Development - Oncology, Genentech, Inc., South San Francisco, CA, USA. · PDBB - Biostatistics, Roche Products Limited, Welwyn Garden City, UK. · Ramón y Cajal University Hospital, Madrid and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Pubmed 29223479
2017
  • Ramón y Cajal University Hospital, Carretera de Colmenar Viejo, 9.100, 28034 Madrid, Spain; Vall d'Hebron Institute of Oncology, Psg. Vall d'Hebron 119-129, Barcelona, Spain. Electronic address: · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, 101 Daehak-ro, Jongro-gu, Seoul, Republic of Korea. · Ramón y Cajal University Hospital, Carretera de Colmenar Viejo, 9.100, 28034 Madrid, Spain; Baselga Institute of Oncology, Ruber & San Camilo Hospitals, Madrid, Spain. · Baselga Institute of Oncology, Hospital Quiron, Plaza Alfonso Comín, 5, Barcelona, Spain. · Barts Cancer Institute, Queen Mary University of London, Old Anatomy Building, Ashfield Street, London, UK. · MD Anderson Cancer Center, University of Texas, 1515 Holcombe Blvd, Houston 77030, TX, USA. · Pubmed 29100169
  • Hospital Sirio Libanes, Adma Jafet St 91, 1308050 São Paulo, Brazil. · Ramon y Cajal University Hospital, Ctra. Colmenar Viejo km. 9, 100, 28034 Madrid, Spain; Vall d'Hebron Institute of Oncology, Centro Cellex, Calle Natzaret 115-117, 08035 Barcelona, Spain. Electronic address: · European Institute of Oncology, Via Ripamonti 435, 20146 Milano, Italy. Electronic address: · Peter MacCallum Cancer Centre, University of Melbourne, Grattan Street 305, 3000 Melbourne, Australia. Electronic address: · Institute of Pathology, Charité Universitätsmedizin Berlin and German Cancer Consortium (DKTK), Campus Mitte, Charitéplatz 1, D-10117 Berlin, Germany. Electronic address: · Baselga Oncological Institute, Quiron Hospital, Plaça d'Alfonso Comín 5, 08023 Barcelona, Spain. Electronic address: · Ramon y Cajal University Hospital, Ctra. Colmenar Viejo km. 9, 100, 28034 Madrid, Spain; Baselga Institute of Oncology, Madrid, Spain. Electronic address: · Pubmed 29061314
  • Memorial Sloan Kettering Cancer Center, New York, New York, United States. · University of Sheffield, Weston Park Hospital, Sheffield, United Kingdom. Electronic address: · Ramón y Cajal University Hospital, Madrid, Spain. · University of Ulm, Ulm, Germany. · Pubmed 29042085
  • UCSF Helen, Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, San Francisco, CA, 94115, USA. · Centre Léon Bérard, Lyon, France. · National Cancer Center, Goyang, Republic of Korea. · H. de Lleida Arnau de Vilanova, Lerida, Spain. · Institut de Cancérologie de l'Ouest, St Herblain-Nantes, France. · University Hospital of Parma, Parma, Italy. · Instituto Português de Oncologia Francisco Gentil, Porto, Portugal. · Korea University Medical Center, Seoul, Republic of Korea. · Ramón y Cajal University Hospital, Madrid and Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. · Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. · Merck& Co., Inc., Kenilworth, NJ, USA. · Checkmate Pharmaceuticals, Cambridge, MA, USA. · Alexion Pharmaceuticals, New Haven, CT, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 28681171
  • Department of Medicine and Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: · Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan. · Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid, Spain; Vall d'Hebron Institute of Oncology, Barcelona, Spain; Instituto Oncológico Baselga, Hospital Quirónsalud, Barcelona, Spain. · Department of Breast Oncology, Istituto Nazionale Tumouri Fondazione G Pascale, Naples, Italy. · Department of Breast Cancer, Beijing 307 Hospital of PLA, Beijing, China. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Department of Gynecology, University Hospital Schleswig-Holstein, Kiel, Germany. · Division of Medical Oncology, Ottawa Hospital Research Institute, Ottawa, ON, Canada. · Department of Radiation Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan. · Medicine Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, BC Cancer Agency, Vancouver, BC, Canada. · Department of Breast Cancer and Reconstruction Surgery, Maria Skłodowska Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland. · Department of Oncology, Ospedale di Macerata, Macerata, Italy. · Department of Surgery, Taipei Veterans General Hospital, National Yang Ming University, Taipei, Taiwan. · Division of Haematology-Oncology, Department of Medicine, University of California, Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Breast Oncology, Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan. · Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan. · Department of Medical Oncology, Université Catholique de Louvain, CHU UCL, Namur, Belgium. · Novartis Pharma SAS, Paris, France. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Syros Pharmaceuticals, Watertown, MA, USA. · Novartis Pharma AG, Basel, Switzerland. · Institut de Cancérologie de l'Ouest-René Gauducheau Centre de Recherche en Cancérologie, Nantes, France. · Pubmed 28576675
  • Memorial Sloan Kettering Cancer Center, New York, New York. · Dana-Farber Cancer Institute, Boston, Massachusetts. · University of California San Francisco Comprehensive Cancer Center, San Francisco, California. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Ramón y Cajal University Hospital, Madrid, Spain. · Institut Curie, Paris, France. · Texas Oncology, Austin, Texas. · Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, Texas. · Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center, New York, New York. · Sarah Cannon Research Institute, Tennessee Oncology PLLC, Nashville, Tennessee. · Eli Lilly and Company, Indianapolis, Indiana. · Pubmed 28533223
  • Leeds Institute of Cancer and Pathology and St James's Institute of Oncology, Leeds, UK. Electronic address: · Ramon y Cajal University Hospital, Madrid, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Baylor-Sammons Cancer Center, Texas Oncology, U.S. Oncology, Dallas, TX, USA. · Medical Oncology Clinic, Jules Bordet Institute, Brussels, Belgium. · Mayo Clinic, Jacksonville, FL, USA. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · The West Clinic, Memphis, TN, USA. · Institut Curie, Paris, France. · Sarah Cannon Research Institute, Nashville, TN, USA. · University of Minnesota, Department of Medicine, Masonic Cancer Center, Minneapolis, MN, USA. · Centre Oscar Lambret, Lille, France. · Ramon y Cajal University Hospital, Madrid, Spain. · Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. · Nektar Therapeutics, San Francisco, CA, USA. · Consultant, Sebastopol, CA, USA. · University of California, San Francisco, CA, USA. · Pubmed 28360015
  • Memorial Sloan Kettering Cancer Center, New York, NY, USA. · H. de Lleida Arnau de Vilanova, Lérida, Spain. · Institut Jules Bordet, Brussels, Belgium. · Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. · Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. · Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA. · Institute of Clinical Research, Odense University Hospital, University of Southern Denmark, Odense, Denmark. · Ramon y Cajal University Hospital, Madrid and Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Massachusetts General Hospital, Boston, MA, USA. · Mayo Clinic, Rochester, MN, USA. · University of Minnesota Masonic Clinical Cancer Center, Minneapolis, MN, USA. · Hospital 12 de Octubre, Madrid, Spain. · Clinique Sainte Elisabeth, Namur, Belgium. · Merck & Co., Inc., Kenilworth, NJ, USA. · Checkmate Pharmaceuticals, Cambridge, MA, USA. · UCSF Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero St., San Francisco, CA, USA. · Pubmed 28324268
  • Hospital Arnau de Vilanova, Valencia, Spain. · Hospital Universitario Ramón y Cajal, Madrid, Spain; Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Hospital Clinic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Vall d'Hebron Institute of Oncology, Barcelona, Spain; Hospital Clinic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Hospital Clínico de Valencia, Valencia, Spain. · Hospital Universitario Ramón y Cajal, Madrid, Spain. · Hospital Clinic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Hospital Universitari Vall d' Hebron, Barcelona, Spain. · Instituto Catalán de Oncología, Hospitalet, Barcelona, Spain. · Complejo Universitario de Santiago de Compostela, Santiago de Compostela, Spain. · Hospital Clinic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Molecular Oncology Laboratory, Barcelona, Spain. · Hospital Universitari Arnau Vilanova, Lleida, Spain. · Hospital Universitari Vall d' Hebron, Barcelona, Spain. · SOLTI Breast Cancer Research Group, Barcelona, Spain. · Vall d'Hebron Institute of Oncology, Barcelona, Spain; Hospital Clinic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. Electronic address: · Pubmed 28238593
  • Medical Oncology Unit, Azienda Ospedaliero-Universitaria di Parma, Via Gramsci 14, 43126, Parma, Italy. · Institut de Cancerologie de l'Ouest, René Gauducheau, Saint-Herblain, France. · Hospital Gasthuisberg, Leuven, Belgium. · Virginia Cancer Specialists, US Oncology Research, Arlington, VA, USA. · Pontificia Universidade Católica do Rio Grande do Sul School of Medicine, Porto Alegre, Brazil. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Ramon y Cajal University Hospital, Madrid, Spain. · Duke University Medical Center, Durham, NC, USA. · Moffitt Cancer Center, Tampa, FL, USA. · University of Szeged, Szeged, Hungary. · Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, Bordeaux, France. · Novartis Pharma AG, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Institut Gustave Roussy, Villejuif, France. · Pubmed 28183331
  • Breast Cancer Clinical Research Unit, CNIO - Spanish National Cancer Research Center, Madrid, Spain. · Medical Oncology Department, Hospital Clinico Universitario, Valencia, Spain. · Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain. · Medical Oncology Department, Hospital de Montepríncipe, Madrid, Spain. · Medical Oncology Department, Hospital Vall d'Hebron, Barcelona, Spain. · Medical Oncology Department, Hospital Ramón y Cajal, Madrid, Spain. · Medical Oncology Department, Hospital Clinico San Carlos, Madrid, Spain. · Medical Oncology Department, Institut Catala d'Oncologia-IDIBELL, L'Hospitalet de Llobregat, Spain. · Medical Oncology Department, MD Anderson Cancer Center, Madrid, Spain. · Medical Oncology Department, Hospital General de Albacete, Albacete, Spain. · Medical Oncology Department, Hospital Lozano Blesa, Zaragoza, Spain. · Medical Oncology Department, Institut Catala d'Oncologia-Josep Trueta, Girona, Spain. · Medical Oncology Department, Hospital Arnau de Vilanova, Valencia, Spain. · Medical Oncology Department, Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain. · Medical Oncology Department, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain. · Breast Cancer Clinical Research Unit, CNIO - Spanish National Cancer Research Center, Madrid, Spain. · GEICAM, Madrid, Spain. · Pathology Department, Hospital Ramon y Cajal, Madrid, Spain. · Molecular Imaging Unit, CNIO - Spanish National Cancer Research Center, Madrid, Spain. · Medical Oncology Department, Hospital Universitario La Princesa, Madrid, Spain. · Pubmed 27587436
  • Breast Cancer Clinical Research Unit, CNIO-Spanish National Cancer Research Center, Madrid, Spain. · Telomeres and Telomerase Group, Molecular Oncology Programme, CNIO-Spanish National Cancer Research Center, Madrid, Spain. · Medical Oncology Department, Hospital Clinico Universitario, Valencia, Spain. · Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain. · Medical Oncology Department, Hospital de Montepríncipe, Madrid, Spain. · Medical Oncology Department, Hospital Vall d´Hebron, Barcelona, Spain. · Medical Oncology Department, Hospital Ramón y Cajal, Madrid, Spain. · Medical Oncology Department, Hospital Clinico San Carlos, Madrid, Spain. · Medical Oncology Department, Institut Catala d'Oncologia-IDIBELL, L'Hospitalet de Llobregat, Spain. · Medical Oncology Department, MD Anderson Cancer Center, Madrid, Spain. · Medical Oncology Department, Hospital General de Albacete, Albacete, Spain. · Medical Oncology Department, Hospital Lozano Blesa, Zaragoza, Spain. · Medical Oncology Department, Institut Catala d'Oncologia-Hospital Dr. Josep Trueta, Girona, Spain. · Medical Oncology Department, Hospital Arnau de Vilanova, Valencia, Spain. · Medical Oncology Department, Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain. · Medical Oncology Department, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain. · GEICAM, Madrid, Spain. · Medical Oncology Department, Hospital Universitario La Princesa, Madrid, Spain. · Pubmed 28423524
  • Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Morphological Sciences Department, Universidad Autónoma de Barcelona, Spain. Electronic address: · Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Morphological Sciences Department, Universidad Autónoma de Barcelona, Spain. · Pathology Department, Virgen del Rocío University Hospital, Sevilla, Spain. · Pathology Department, Hospital Lluis Alcanys, Xàtiva, Spain. · Pathology Department, Hospital de la Ribera, Alcira, Spain. · Pathology Department, Hospital de Navarra, Pamplona, Spain. · Pathology Department, Salamanca University Hospital, Spain. · Pathology Department, Complejo Hospitalario de Jaén, Spain. · Pathology Department, Hospital Arnau de Vilanova, Lérida, Spain. · Pathology Department, Fundación Jiménez Díaz, Madrid, Spain. · Breast Cancer Unit, Vall d'Hebron University Hospital, Barcelona, Spain. · Medical Oncology Department, Baselga Institute of Oncology, Quiron Hospital, Barcelona, Spain. · Medical Oncology Department, Ramón y Cajal University Hospital, Madrid, Spain; Vall d'Hebron Oncology Institute, Barcelona, Spain. · Pubmed 28254641
  • Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain. · Hospital Provincial de Castellón, Castellón, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Pathology, Hospital Clínico Universitario de Valencia, Spain. · Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · Hospital Clínico San Cecilio, Complejo Hospitalario de Granada, Granada, Spain. · Instituto Valenciano de Oncología, Valencia, Spain. · Hospital Universitario Quirón de Madrid, Madrid, Spain. · Hospital Virgen de la Salud, Toledo, Spain. · Pathology Department, Hospital Vall d'Hebron, Barcelona, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · University of North Carolina, Chapel Hill, North Carolina. · Ramón y Cajal University Hospital, Madrid, Spain. · University of Messina, Messina, Italy. · Hospital del Mar, Barcelona, Spain. · ICREA, Barcelona, Spain. · Department of Hematology and Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Pubmed 28249905
  • University of Kansas Medical Center, Westwood, Kansas. · Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain. · Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain. · University of Kansas Medical Center, Westwood, Kansas. · Medical Oncology Department, Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú. · Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. · Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain. · Laboratory of Translational Oncology. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain. · Oncology Department, Hospital Clínico, Valladolid, Spain. · Department of Oncology, Ramon y Cajal University Hospital, Madrid, Spain. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. · Department of Pathology & Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. · Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain. · Pubmed 27301700
2016
  • Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA. · Ramon y Cajal University Hospital, Madrid, Spain. · Vall D'Hebron Institute of Oncology, Barcelona, Spain. · Baylor-Sammons Cancer Center, Texas Oncology, U.S. Oncology, Dallas, TX, USA. · Pubmed 27023712
  • Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA. · Medical Oncology Department, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Paseo Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Faculty of Medicine, Universitat Autònoma de Barcelona (UAB), Campus de la UAB, Plaza Cívica, 08193 Bellaterra, Barcelona, Spain. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA. · Ramon y Cajal University Hospital, Ctra. de Colmenar Viejo, 28034 Madrid, Spain. · Medica Scientia Innovation Research (MedSIR), C/ Rambla Catalunya 2, 2D, 08007 Barcelona, Spain. · Pubmed 27000962
  • a Department of Medical Oncology , Ramon y Cajal University Hospital , Madrid , Spain. · b Department of Medical Oncology , Vall d'Hebron Institute of Oncology , Barcelona , Spain. · Pubmed 26881332
  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain and Ramony Cajal University Hospital, Madrid, Spain. · University of California Los Angeles, Los Angeles, CA, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · MD Anderson Cancer Center, Houston, TX, USA. · Sunnybrook Odette Cancer Centre, Toronto, Canada. · Merrimack Pharmaceuticals, Inc., 1 Kendall Square, Suite B7201, Cambridge, MA, 02139-1670, USA. · Merrimack Pharmaceuticals, Inc., 1 Kendall Square, Suite B7201, Cambridge, MA, 02139-1670, USA. · Sarah Cannon Research Institute, and Tennessee Oncology, PLLC, Nashville, TN, USA. · Pubmed 27259714
  • Biochemistry Department, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas "Alberto Sols" (CSIC-UAM), IdiPAZ, Madrid, Spain. · Preclinical Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. · Pathology Department, MD Anderson Cancer Center, Madrid, Spain. · Breast Cancer and Systems Biology Unit, ProCURE, Catalan Institute of Oncology, IDIBELL, L'Hospitalet del Llobregat, Barcelona, Spain. · Translational Research Laboratory, MD Anderson Internacional Foundation, Madrid, Spain. · Cytogenetics Department, MD Anderson Cancer Center, Madrid, Spain. · Pathology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain. · Oncology Department, MD Anderson Cancer Center, Madrid, Spain. · Clinical Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autonoma de Barcelona, Barcelona, Spain. · Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Molecular Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. · Pathology Department, Hospital Vall d'Hebron University, Barcelona, Spain. · Pathology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Pubmed 27462779
  • Breast Surgical Oncology Unit, Hospital Universitario Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · Pathology Department, Hospital Universitario Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Medical Oncology, Hospital Universitario Vall d'Hebron, Barcelona, Spain. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Breast Surgical Oncology Unit, Hospital Universitario Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · Pubmed 27357178
2015
  • Vall d'Hebron Institute of Oncology, Barcelona, Spain and Ramon y Cajal University Hospital, Madrid, Spain. Electronic address: · Institut Curie, Paris, France. · National Cancer Center, Goyang-si, Republic of Korea. · Centre Antoine Lacassagne, Nice, France. · Centre Léon Bérard, Lyon, France. · University of California, Los Angeles, CA, USA. · Centre Oscar Lambret, Lille, France; University Hospital, Lille, France. · Hôpital Saint-Louis, Paris, France. · Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · National Center for Tumor Diseases, University Hospital, Heidelberg, Germany. · Severance Hospital, Sinchon-dong, Seodaemun-gu, Seoul, South Korea. · Centre Jean Perrin, Clermont-Ferrand, France. · Tampere University Hospital and University of Tampere, Tampere, Finland. · Sansum Clinic, Santa Barbara, CA, USA. · Università di Modena e Reggio Emilia, Modena, Italy. · Hospital Universitario 12 de Octubre, Madrid, Spain. · Comprehensive Cancer Center, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland. · Boehringer Ingelheim, Paris, France. · Boehringer Ingelheim, Reims, France. · Pubmed 26596672
  • Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Oncology Department, Ramon y Cajal University Hospital, Madrid, Spain. · Department of Quantitative Science, Clinical Outcomes Solutions, 3709 North Campbell, Tucson, AZ, USA. · Department of Oncology, Leeds Institute of Cancer and Pathology, and St James's Institute of Oncology, University of Leeds, Leeds, LS9 7TF, England, UK. · Division of Hematology/Oncology, Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA. · Medical Oncology Clinic, Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, University of Montreal, Montreal, QC, Canada. · Formerly of Eisai Ltd, Hatfield, England, UK. · Section of Hematology/Oncology, Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA. · Department of Global Value and Access Strategy, Eisai Inc., Woodcliff Lake, NJ, USA. · Department of Oncology, Leeds Institute of Cancer and Pathology, and St James's Institute of Oncology, University of Leeds, Leeds, LS9 7TF, England, UK. · Pubmed 26567010
  • Mayo Clinic, Jacksonville, FL, USA. Electronic address: · Medical Oncology Clinic, Jules Bordet Institute, Brussels, Belgium. · Baylor-Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. · University of California, San Francisco, CA, USA. · University of Leeds and St James's University Hospital, Leeds, UK. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · The West Clinic, Memphis, TN, USA. · Institut Curie, Paris, France. · Sarah Cannon Research Institute, Nashville, TN, USA. · University of Minnesota Department of Medicine and Masonic Cancer Center, Minneapolis, MN, USA. · Centre Oscar Lambret, Lille, France. · Mayo Clinic, Jacksonville, FL, USA. · Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. · Nektar Therapeutics, San Francisco, CA, USA. · Sebastopol, CA, USA. · Vall d'Hebron Institute of Oncology, Barcelona, Spain; Ramon y Cajal University Hospital, Madrid, Spain. · Pubmed 26482278
  • Section of Oncology and Clinical Research, Leeds Institute of Cancer and Pathology, University of Leeds and Leeds Teaching Hospitals Trust, Leeds, UK. · St James' Institute of Oncology, St James' University Hospital, University of Leeds, Bexley Wing, Level 4, Beckett Street, Leeds, UK. · Department of Oncology, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Department of Oncology, Ramon y Cajal University Hospital, Madrid, Spain. · Section of Hematology/Oncology, Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA. · Department of Medicine, University of Montreal, Montreal, QC, Canada. · Medical Oncology Clinic, Medicine Department, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. · Oncology Imaging, Eisai Inc., Woodcliff Lake, NJ, USA. · Oncology PCU, Clinical Development, Eisai Inc., Woodcliff Lake, NJ, USA. · Department of Medical Affairs, Eisai Inc., Woodcliff Lake, NJ, USA. · Department of Medical Oncology, US Oncology, Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX, USA. · Section of Oncology and Clinical Research, Leeds Institute of Cancer and Pathology, University of Leeds and Leeds Teaching Hospitals Trust, Leeds, UK. · Division of Hematology/Oncology, Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA. · Pubmed 27391598
  • Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain. · Oncology Experimental Therapeutics Unit, IRCCS Humanitas Clinical and Research Institute, Rozzano, Milan, Italy. · Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Division of Pathology, IRCCS Humanitas Clinical and Research Institute, Rozzano, Milan, Italy, University of Milan, Milan, Italy. · Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands. · Cancer Pharmacology Laboratory, AIRC Start-Up Unit, University of Pisa, Pisa, Italy. · Pathology Department, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain. · Division of Oncology and Hematology, IRCCS Humanitas Clinical and Research Institute, Rozzano, Milan, Italy. · Deparment of Clinical and Biomedical Sciences "Luigi Sacco", University of Milan, Milan, Italy. · Ramon y Cajal University Hospital, Madrid, Spain. · Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. · Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 26452030
Miscellaneous institutions in Madrid
2017
  • Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain. · Hospital Provincial de Castellón, Castellón, Spain. · GEICAM, Spanish Breast Cancer Group, Madrid, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Pathology, Hospital Clínico Universitario de Valencia, Spain. · Complejo Hospitalario Universitario A Coruña, A Coruña, Spain. · Hospital Clínico San Cecilio, Complejo Hospitalario de Granada, Granada, Spain. · Instituto Valenciano de Oncología, Valencia, Spain. · Hospital Universitario Quirón de Madrid, Madrid, Spain. · Hospital Virgen de la Salud, Toledo, Spain. · Pathology Department, Hospital Vall d'Hebron, Barcelona, Spain. · Fundación Jiménez Díaz, Madrid, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · University of North Carolina, Chapel Hill, North Carolina. · Ramón y Cajal University Hospital, Madrid, Spain. · University of Messina, Messina, Italy. · Hospital del Mar, Barcelona, Spain. · ICREA, Barcelona, Spain. · Department of Hematology and Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Pubmed 28249905
2016
  • Medical Oncology Department, MD Anderson Cancer Center, Madrid, C/ Arturo Soria, 270, 28033 - Madrid. Spain. · Pubmed 26278712
Miscellaneous institutions in Barcelona
2017
  • Memorial Sloan Kettering Cancer Center, New York, New York. · Dana-Farber Cancer Institute, Boston, Massachusetts. · University of California San Francisco Comprehensive Cancer Center, San Francisco, California. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Ramón y Cajal University Hospital, Madrid, Spain. · Institut Curie, Paris, France. · Texas Oncology, Austin, Texas. · Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, Texas. · Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center, New York, New York. · Sarah Cannon Research Institute, Tennessee Oncology PLLC, Nashville, Tennessee. · Eli Lilly and Company, Indianapolis, Indiana. · Pubmed 28533223
  • Medical Oncology Unit, Azienda Ospedaliero-Universitaria di Parma, Via Gramsci 14, 43126, Parma, Italy. · Institut de Cancerologie de l'Ouest, René Gauducheau, Saint-Herblain, France. · Hospital Gasthuisberg, Leuven, Belgium. · Virginia Cancer Specialists, US Oncology Research, Arlington, VA, USA. · Pontificia Universidade Católica do Rio Grande do Sul School of Medicine, Porto Alegre, Brazil. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Ramon y Cajal University Hospital, Madrid, Spain. · Duke University Medical Center, Durham, NC, USA. · Moffitt Cancer Center, Tampa, FL, USA. · University of Szeged, Szeged, Hungary. · Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, Bordeaux, France. · Novartis Pharma AG, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Institut Gustave Roussy, Villejuif, France. · Pubmed 28183331
  • University of Kansas Medical Center, Westwood, Kansas. · Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain. · Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain. · University of Kansas Medical Center, Westwood, Kansas. · Medical Oncology Department, Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú. · Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. · Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain. · Laboratory of Translational Oncology. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain. · Oncology Department, Hospital Clínico, Valladolid, Spain. · Department of Oncology, Ramon y Cajal University Hospital, Madrid, Spain. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. · Department of Pathology & Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. · Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain. · Pubmed 27301700
2016
  • Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA. · Ramon y Cajal University Hospital, Madrid, Spain. · Vall D'Hebron Institute of Oncology, Barcelona, Spain. · Baylor-Sammons Cancer Center, Texas Oncology, U.S. Oncology, Dallas, TX, USA. · Pubmed 27023712
  • Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA. · Medical Oncology Department, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Paseo Vall d'Hebron 119-129, 08035 Barcelona, Spain. · Faculty of Medicine, Universitat Autònoma de Barcelona (UAB), Campus de la UAB, Plaza Cívica, 08193 Bellaterra, Barcelona, Spain. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA. · Ramon y Cajal University Hospital, Ctra. de Colmenar Viejo, 28034 Madrid, Spain. · Medica Scientia Innovation Research (MedSIR), C/ Rambla Catalunya 2, 2D, 08007 Barcelona, Spain. · Pubmed 27000962
  • a Department of Medical Oncology , Ramon y Cajal University Hospital , Madrid , Spain. · b Department of Medical Oncology , Vall d'Hebron Institute of Oncology , Barcelona , Spain. · Pubmed 26881332
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Hospital General Universitario and Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Hopital Sant Louis, Paris, France. · Pharma-Mar, Clinical R&D, Colmenar Viejo, Madrid, Spain. · Institut Gustave Roussy, Villejuif, France. · Pubmed 27266804
  • Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK. · Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK; Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK. · Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK. · Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, BC V5Z 1L3, Canada. · Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK. · DNA Damage Response Biology Area, Oncology IMED, AstraZeneca, Alderley Park, Macclesfield SK10 4TG, UK. · OHSU Knight Cancer Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA. · Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain. · Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY 10065, USA. · Translational Research Department, Institut Curie, 26 rue d'Ulm, Paris 75005, France. · Huntsman Cancer Institute, Salt Lake City, UT 84112, USA. · Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK; Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK. Electronic address: · Pubmed 27641504
  • Preclinical and Clinical Research Programs, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Breast Surgical Unit, Breast Cancer Center, Hospital Universitario Vall d´Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · Division of Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. · Department of Medical Oncology, Hospital Clínic of Barcelona, Barcelona, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain. · Department of Biochemistry and Molecular Biology, Universitat Autonoma de Barcelona, Campus de la UAB, Bellaterra, Spain. · Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain. · Pubmed 27602583
  • Breast Surgical Oncology Unit, Hospital Universitario Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · Pathology Department, Hospital Universitario Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Medical Oncology, Hospital Universitario Vall d'Hebron, Barcelona, Spain. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Breast Surgical Oncology Unit, Hospital Universitario Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · Pubmed 27357178
2015
  • Sarah Cannon Research Institute and the Tennessee Oncology, PLLC, 250 25th Avenue North, Suite 100, Nashville, TN, 37203, USA. · University of Pittsburgh Medical Center, Pittsburgh, PA, USA. · Weston Park Hospital, Sheffield Cancer Research Center, Sheffield, England. · Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, and Istituto Oncologico Veneto IRCCS, Padova, Italy. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Celgene Corporation, Summit, NJ, USA. · Centre de Lutte Contre le Cancer d'Auvergne, Clermont Ferrand, France. · Texas Oncology-Baylor Charles A. Sammons Center; US Oncology, Dallas, TX, USA. · Celgene Corporation, Summit, NJ, USA. · Celgene Corporation, Summit, NJ, USA. · Celgene Corporation, Summit, NJ, USA. · Celgene Corporation, Summit, NJ, USA. · Breast Center, University of Munich, Munich, Germany. · Pubmed 26673577
  • Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Oncology Department, Ramon y Cajal University Hospital, Madrid, Spain. · Department of Quantitative Science, Clinical Outcomes Solutions, 3709 North Campbell, Tucson, AZ, USA. · Department of Oncology, Leeds Institute of Cancer and Pathology, and St James's Institute of Oncology, University of Leeds, Leeds, LS9 7TF, England, UK. · Division of Hematology/Oncology, Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA. · Medical Oncology Clinic, Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, University of Montreal, Montreal, QC, Canada. · Formerly of Eisai Ltd, Hatfield, England, UK. · Section of Hematology/Oncology, Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA. · Department of Global Value and Access Strategy, Eisai Inc., Woodcliff Lake, NJ, USA. · Department of Oncology, Leeds Institute of Cancer and Pathology, and St James's Institute of Oncology, University of Leeds, Leeds, LS9 7TF, England, UK. · Pubmed 26567010
  • Section of Oncology and Clinical Research, Leeds Institute of Cancer and Pathology, University of Leeds and Leeds Teaching Hospitals Trust, Leeds, UK. · St James' Institute of Oncology, St James' University Hospital, University of Leeds, Bexley Wing, Level 4, Beckett Street, Leeds, UK. · Department of Oncology, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Department of Oncology, Ramon y Cajal University Hospital, Madrid, Spain. · Section of Hematology/Oncology, Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA. · Department of Medicine, University of Montreal, Montreal, QC, Canada. · Medical Oncology Clinic, Medicine Department, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. · Oncology Imaging, Eisai Inc., Woodcliff Lake, NJ, USA. · Oncology PCU, Clinical Development, Eisai Inc., Woodcliff Lake, NJ, USA. · Department of Medical Affairs, Eisai Inc., Woodcliff Lake, NJ, USA. · Department of Medical Oncology, US Oncology, Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX, USA. · Section of Oncology and Clinical Research, Leeds Institute of Cancer and Pathology, University of Leeds and Leeds Teaching Hospitals Trust, Leeds, UK. · Division of Hematology/Oncology, Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA. · Pubmed 27391598
  • Human Oncology and Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Department of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, 524 Burrill Hall, Urbana, IL 61801, USA. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Passeig Vall d'Hebron 119-129, Barcelona 08035, Spain. Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Hospital Clinic Barcelona, C/Rosselló 149-153, Barcelona 08035, Spain. · Massachusetts General Hospital Cancer Center and Harvard Medical School, 425 13th Street, Charlestown, MA 02129, USA. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Molecular Pharmacology and Chemistry Program and Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medical Oncology, VHIO, Barcelona 08035, Spain. Universitat Autònoma de Barcelona, Plaza Cívica, Campus UAB, 08193 Bellaterra, Spain. · Experimental Therapeutics Group, VHIO, Barcelona 08035, Spain. · Department of Medical Oncology, VHIO, Barcelona 08035, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Passeig Vall d'Hebron 119-129, Barcelona 08035, Spain. · Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Molecular Pharmacology and Chemistry Program and Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Weill Cornell Medical College, New York, NY 10065, USA. · Human Oncology and Pathogenesis Program and Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA. · Pubmed 25877889
  • Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Pg Vall d'Hebron, 119-129, 08035, Barcelona, Spain; Breast Cancer Unit, Department of Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Pathology Department, Vall d'Hebron University Hospital, Pg Vall d'Hebron, 119-129, 08035, Barcelona, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Pg Vall d'Hebron, 119-129, 08035, Barcelona, Spain. · Department of Medical Oncology, Lozano Blesa University Hospital, San Juan Bosco, 15, 50009, Zaragoza, Spain. · Breast Cancer Unit, Department of Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Breast Cancer Surgical Oncology, Vall d'hebron Institute of Oncology (VHIO), Barcelona, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Pg Vall d'Hebron, 119-129, 08035, Barcelona, Spain; Breast Cancer Unit, Department of Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Electronic address: · Pubmed 25687451
  • Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, New York. · Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Frontier Science (Scotland) Ltd., Inverness-shire, Scotland. · Clinical Research, Monogram Biosciences, Inc., South San Francisco, California. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Breast Center, Department of Obstetrics and Gynecology, and CCC LMU, University of Munich, Munich, Germany. · Genetics and Genomics Program, Yale School of Medicine, New Haven, Connecticut. · Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania. · Department of Gynecology and Midwifery, University Hospital Kiel, Kiel, Germany. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain. · Medical Oncology Department, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Jules Bordet Institute, Brussels, Belgium. · Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, New York. Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 25467182
2013
  • 1] Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain [2] Breast Cancer Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain [3] Medical Oncology Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Medical Oncology Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA. · 1] Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain [2] Morphological Sciences Department, Universitat Autònoma de Barcelona, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Cancer Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Molecular Oncology Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Stem Cells and Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Department of Medical Oncology, Dubai Hospital, U.A.E. · 1] Breast Cancer Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain [2] Medical Oncology Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Pubmed 24384914
2011
  • Breast Cancer Program, Vall D’Hebron Institute of Oncology, Barcelona, Spain. · Pubmed 21475127
2014
  • Department of Pathology, Hospital Quiron Barcelona, Barcelona, Spain. · Pubmed 24689830
2012
  • Experimental Therapeutics Laboratory, Vall d'Hebron Institute of Oncology (VHIO), Pg Vall d'Hebron, Barcelona, Spain. · Pubmed 22915752
  • Breast Cancer Program, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Pubmed 22884504
2011
  • Departments of Medical Oncology and Molecular Pathology, Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain. · Pubmed 21321214
2010
  • Breast Unit, Service of Obstetrics and Gynecology, Hospital Vail d'Hebron, Autonomous University of Barcelona, Barcelona, Spain. · Pubmed 20968147
  • Corporació Sanitària Parc Taulí, Barcelona, Spain. · Pubmed 20947484
Miscellaneous cities in Spain
2016
  • The Breast Cancer Now Research Centre, Institute of Cancer Research, London, United Kingdom. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Weill Cornell Medicine, Cornell University, New York, New York. · Medical Oncology, Hospital Vall d'Hebron, Spain. · Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York. · The Breast Cancer Now Research Centre, Institute of Cancer Research, London, United Kingdom. Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom. · The Breast Cancer Now Research Centre, Institute of Cancer Research, London, United Kingdom. Breast Unit, Royal Marsden Hospital, London, United Kingdom. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Pubmed 27020857
2015
  • Medical Oncology Department, Corporació Sanitaria Parc Taulí, Sabadell, Spain. · Pubmed 25797142
2014
  • Medical Oncology Department, Corporació Sanitaria Parc Taulí, Sabadell, Spain. · Pubmed 25213317
Memorial Sloan-Kettering Cancer Center
2014
  • *Authors contributed equally to this work. · *Authors contributed equally to this work.Affiliations of authors: Preclinical Research (JLPP, BM, ME, RV, MZF, KP, VS, AP, JA) and Clinical Research Programs (PN, JC, ITR), Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain (VP); Human Oncology and Pathogenesis Program (HOPP) and Memorial Sloan Kettering Cancer Center, New York, NY (MS, JB); Instituto de Biología Molecular y Celular del Cáncer, Campus Miguel de Unamuno, Salamanca, Spain (AP); Lineberger Comprehensive Cancer Center, Chapel Hill, NC (CMP); Department of Biochemistry and Molecular Biology, Universitat Autonoma de Barcelona, Campus de la UAB, Bellaterra, Spain (JA); Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (JA). · Pubmed 25253614
  • : Breast Cancer Unit (AP, BA, MV, JC), Department of Medical Oncology (AP, BA, MV, JC, JT), and Translational Genomics Group (AP, MV), Vall d'Hebron Institute of Oncology Barcelona, Spain; Lineberger Comprehensive Cancer Center (LAC, JSP, CMP), Department of Genetics (CMP), and Department of Pathology and Laboratory Medicine (CMP), University of North Carolina, Chapel Hill, NC; Memorial Sloan-Kettering Cancer Center, New York (JB). · : Breast Cancer Unit (AP, BA, MV, JC), Department of Medical Oncology (AP, BA, MV, JC, JT), and Translational Genomics Group (AP, MV), Vall d'Hebron Institute of Oncology Barcelona, Spain; Lineberger Comprehensive Cancer Center (LAC, JSP, CMP), Department of Genetics (CMP), and Department of Pathology and Laboratory Medicine (CMP), University of North Carolina, Chapel Hill, NC; Memorial Sloan-Kettering Cancer Center, New York (JB). · Pubmed 25139534
2014
  • José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY; Javier Cortés, Vall d'Hebron University Hospital, Barcelona, Spain; Seock-Ah Im, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Emma Clark and Graham Ross, Roche Products, Welwyn Garden City, United Kingdom; Astrid Kiermaier, F. Hoffmann-La Roche, Basel, Switzerland; and Sandra M. Swain, Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC. · José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY; Javier Cortés, Vall d'Hebron University Hospital, Barcelona, Spain; Seock-Ah Im, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Emma Clark and Graham Ross, Roche Products, Welwyn Garden City, United Kingdom; Astrid Kiermaier, F. Hoffmann-La Roche, Basel, Switzerland; and Sandra M. Swain, Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC. · Pubmed 25332247
  • Cristina Saura and Javier Cortés, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona; Jose A. Garcia-Saenz, Hospital Clinico San Carlos; Miguel Martin, Hospital Gregorio Maranon, Universidad Complutense, Madrid, Spain; Binghe Xu, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China; Wael Harb, Horizon Medical Group, Lafayette, IN; Rebecca Moroose, University of Florida Health Cancer Center, Orlando, FL; Timothy Pluard, Washington University School of Medicine, St Louis, MO; Corinne Kiger, Pfizer Global Research and Development, Paris; Caroline Germa, Novartis Pharma, Rueil-Malmaison, France; Kongming Wang, Pfizer, Pearl River; José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY; and Sung-Bae Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · Cristina Saura and Javier Cortés, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona; Jose A. Garcia-Saenz, Hospital Clinico San Carlos; Miguel Martin, Hospital Gregorio Maranon, Universidad Complutense, Madrid, Spain; Binghe Xu, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China; Wael Harb, Horizon Medical Group, Lafayette, IN; Rebecca Moroose, University of Florida Health Cancer Center, Orlando, FL; Timothy Pluard, Washington University School of Medicine, St Louis, MO; Corinne Kiger, Pfizer Global Research and Development, Paris; Caroline Germa, Novartis Pharma, Rueil-Malmaison, France; Kongming Wang, Pfizer, Pearl River; José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY; and Sung-Bae Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · Pubmed 25287822
2013
  • aVall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain bMedStar Washington Hospital Center, Washington Cancer Institute, Washington, District of Columbia cMid Ohio Oncology/Hematology Inc., The Mark H. Zangmeister Center, Columbus, Ohio dGenentech, South San Francisco, California eMemorial Sloan-Kettering Cancer Center, New York, New York, USA fRiga East University Hospital Oncology Center, Riga, Latvia gDaugavpils Reǵionālā Slimnīca, Daugavpils, Latvia hGesundheitszentrum Fricktal, Spital Rheinfelden & Laufenburg, Rheinfelden, Switzerland iNational Hospital Organization Osaka National Hospital, Osaka-City, Osaka, Japan jRoche Products Limited, Welwyn Garden City, UK kPharsight, Montreal, Quebec, Canada. · Pubmed 23969513
University of North Carolina Chapel Hill
2014
  • : Breast Cancer Unit (AP, BA, MV, JC), Department of Medical Oncology (AP, BA, MV, JC, JT), and Translational Genomics Group (AP, MV), Vall d'Hebron Institute of Oncology Barcelona, Spain; Lineberger Comprehensive Cancer Center (LAC, JSP, CMP), Department of Genetics (CMP), and Department of Pathology and Laboratory Medicine (CMP), University of North Carolina, Chapel Hill, NC; Memorial Sloan-Kettering Cancer Center, New York (JB). · : Breast Cancer Unit (AP, BA, MV, JC), Department of Medical Oncology (AP, BA, MV, JC, JT), and Translational Genomics Group (AP, MV), Vall d'Hebron Institute of Oncology Barcelona, Spain; Lineberger Comprehensive Cancer Center (LAC, JSP, CMP), Department of Genetics (CMP), and Department of Pathology and Laboratory Medicine (CMP), University of North Carolina, Chapel Hill, NC; Memorial Sloan-Kettering Cancer Center, New York (JB). · Pubmed 25139534
2014
  • University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain; Weill Cornell Medical College, New York, New York, USA; Jules Bordet Institute, Brussels, Belgium; University of Leeds and St James's Institute of Oncology, Leeds, UK; Formerly of Eisai Ltd, Hatfield, UK; Eisai Inc., Woodcliff Lake, New Jersey, USA; NJS Associates Company, Somerset, New Jersey USA; Baylor-Charles A. Sammons Cancer Center, Texas Oncology, and US Oncology, Dallas, Texas, USA. · Pubmed 24682463
Universidad de Salamanca
2014
  • *Authors contributed equally to this work. · *Authors contributed equally to this work.Affiliations of authors: Preclinical Research (JLPP, BM, ME, RV, MZF, KP, VS, AP, JA) and Clinical Research Programs (PN, JC, ITR), Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain (VP); Human Oncology and Pathogenesis Program (HOPP) and Memorial Sloan Kettering Cancer Center, New York, NY (MS, JB); Instituto de Biología Molecular y Celular del Cáncer, Campus Miguel de Unamuno, Salamanca, Spain (AP); Lineberger Comprehensive Cancer Center, Chapel Hill, NC (CMP); Department of Biochemistry and Molecular Biology, Universitat Autonoma de Barcelona, Campus de la UAB, Bellaterra, Spain (JA); Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (JA). · Pubmed 25253614
2013
  • Medical Oncology Department, Institute of Biomedical Research of Córdoba, Reina Sofía University Hospital, Spain. · Pubmed 23863615
Harvard University
2012
  • Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA. · Pubmed 22393084
2012
  • Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02129, USA. · Pubmed 22718860
  • Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA 02114, USA. · Pubmed 22149875
University of Leeds
2011
  • Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Pubmed 21376385
2014
  • University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain; Weill Cornell Medical College, New York, New York, USA; Jules Bordet Institute, Brussels, Belgium; University of Leeds and St James's Institute of Oncology, Leeds, UK; Formerly of Eisai Ltd, Hatfield, UK; Eisai Inc., Woodcliff Lake, New Jersey, USA; NJS Associates Company, Somerset, New Jersey USA; Baylor-Charles A. Sammons Cancer Center, Texas Oncology, and US Oncology, Dallas, Texas, USA. · Pubmed 24682463
2011
  • Clinical Cancer Research Groups, Leeds Institute of Molecular Medicine and St James's Institute of Oncology, Leeds, England. · Pubmed 21738118
2010
  • Leeds Institute of Molecular Medicine, St. James University Hospital, Leeds, United Kingdom. · Pubmed 20299316
37 Other Locations Show
Yearly article counts 21512201516206820
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.